Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Apr. 18, 2014 |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'Intel Corp | ' |
Entity Central Index Key | '0000050863 | ' |
Company Fiscal Year End Date | '--12-27 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 29-Mar-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q1 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock Shares Outstanding | ' | 4,978 |
Consolidated_Condensed_Stateme
Consolidated Condensed Statements of Income (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Net revenue | $12,764 | $12,580 |
Cost of sales | 5,151 | 5,514 |
Gross margin | 7,613 | 7,066 |
Research and development | 2,846 | 2,527 |
Marketing, general and administrative | 2,047 | 1,947 |
Restructuring and asset impairment charges | 137 | 0 |
Operating expenses | 5,103 | 4,547 |
Operating income | 2,510 | 2,519 |
Gains (losses) on equity investments, net | 48 | -26 |
Interest and other, net | 112 | -50 |
Income before taxes | 2,670 | 2,443 |
Provision for taxes | 740 | 398 |
Net income | 1,930 | 2,045 |
Basic earnings per common share (in dollars per share) | $0.39 | $0.41 |
Diluted earnings per common share (in dollars per share) | $0.38 | $0.40 |
Cash dividends declared per common share (in dollars per share) | $0.45 | $0.45 |
Weighted average common shares outstanding: | ' | ' |
Basic (shares) | 4,974 | 4,948 |
Diluted (shares) | 5,117 | 5,080 |
Operating Expense [Member] | ' | ' |
Amortization of acquisition-related intangibles | $73 | $73 |
Consolidated_Condensed_Stateme1
Consolidated Condensed Statements of Comprehensive Income (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Consolidated Condensed Statements Of Comprehensive Income [Abstract] | ' | ' |
Net income | $1,930 | $2,045 |
Other comprehensive income, net of tax: | ' | ' |
Change in net unrealized holding gains (losses) on available-for-sale investments | -77 | 173 |
Change in net deferred tax asset valuation allowance | -2 | 0 |
Change in net unrealized holding gains (losses) on derivatives | 14 | -156 |
Change in net prior service costs | -42 | 1 |
Change in actuarial valuation | -2 | 34 |
Change in net foreign currency translation adjustment | 22 | -63 |
Other comprehensive income (loss) | -87 | -11 |
Total comprehensive income | $1,843 | $2,034 |
Consolidated_Condensed_Balance
Consolidated Condensed Balance Sheets (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $4,777 | $5,674 |
Short-term investments | 5,234 | 5,972 |
Trading assets | 9,035 | 8,441 |
Accounts receivable, net | 3,505 | 3,582 |
Inventories | 3,763 | 4,172 |
Deferred tax assets | 2,507 | 2,594 |
Other current assets | 1,733 | 1,649 |
Total current assets | 30,554 | 32,084 |
Property, plant and equipment, net of accumulated depreciation of $42,791 ($41,988 as of December 28, 2013) | 32,502 | 31,428 |
Marketable equity securities | 6,085 | 6,221 |
Other long-term investments | 1,765 | 1,473 |
Goodwill | 10,617 | 10,513 |
Identified intangible assets, net | 4,963 | 5,150 |
Other long-term assets | 5,446 | 5,489 |
Total assets | 91,932 | 92,358 |
Current liabilities: | ' | ' |
Short-term debt | 36 | 281 |
Accounts payable | 3,010 | 2,969 |
Accrued compensation and benefits | 1,979 | 3,123 |
Accrued advertising | 1,019 | 1,021 |
Deferred income | 2,171 | 2,096 |
Other accrued liabilities | 5,337 | 4,078 |
Total current liabilities | 13,552 | 13,568 |
Long-term debt | 13,172 | 13,165 |
Long-term deferred tax liabilities | 4,302 | 4,397 |
Other long-term liabilities | 2,868 | 2,972 |
Contingencies (Note 19) | ' | ' |
Stockholders’ equity: | ' | ' |
Preferred stock | 0 | 0 |
Common stock and capital in excess of par value, 4,972 shares issued and outstanding (4,967 as of December 28, 2013) | 22,166 | 21,536 |
Accumulated other comprehensive income (loss) | 1,156 | 1,243 |
Retained earnings | 34,716 | 35,477 |
Total stockholders’ equity | 58,038 | 58,256 |
Total liabilities and stockholders’ equity | $91,932 | $92,358 |
Consolidated_Condensed_Balance1
Consolidated Condensed Balance Sheets (Parenthetical) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Current assets: | ' | ' |
Accumulated depreciation | $42,791 | $41,988 |
Stockholders’ equity: | ' | ' |
Common stock, shares issued | 4,972 | 4,967 |
Common stock, shares outstanding | 4,972 | 4,967 |
Consolidated_Condensed_Stateme2
Consolidated Condensed Statements of Cash Flows (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Cash and cash equivalents, beginning of period | $5,674 | $8,478 |
Cash flows provided by (used for) operating activities: | ' | ' |
Net income | 1,930 | 2,045 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Depreciation | 1,720 | 1,682 |
Share-based compensation | 283 | 295 |
Restructuring and asset impairment charges | 137 | 0 |
Excess tax benefit from share-based payment arrangements | -7 | -1 |
Amortization of intangibles | 287 | 382 |
(Gains) losses on equity investments, net | -48 | 26 |
Deferred taxes | -25 | -56 |
Changes in assets and liabilities: | ' | ' |
Accounts receivable | 78 | 293 |
Inventories | 405 | 372 |
Accounts payable | -95 | -17 |
Accrued compensation and benefits | -1,229 | -1,370 |
Income taxes payable and receivable | 200 | 257 |
Other assets and liabilities | -135 | 377 |
Total adjustments | 1,571 | 2,240 |
Net cash provided by operating activities | 3,501 | 4,285 |
Cash flows provided by (used for) investing activities: | ' | ' |
Additions to property, plant and equipment | -2,689 | -2,174 |
Acquisitions, net of cash acquired | -108 | -98 |
Purchases of available-for-sale investments | -2,509 | -3,475 |
Sales of available-for-sale investments | 174 | 304 |
Maturities of available-for-sale investments | 2,913 | 1,711 |
Purchases of trading assets | -3,225 | -5,191 |
Maturities and sales of trading assets | 2,693 | 3,558 |
Collection of loans receivable | 8 | 8 |
Investments in non-marketable equity investments | -144 | -35 |
Return of equity method investments | 0 | 13 |
Proceeds from divestitures | 150 | 0 |
Other investing | -12 | 95 |
Net cash used for investing activities | -2,749 | -5,317 |
Cash flows provided by (used for) financing activities: | ' | ' |
Increase (decrease) in short-term debt, net | -245 | -224 |
Excess tax benefit from share-based payment arrangements | 7 | 1 |
Proceeds from sales of shares through employee equity incentive plans | 479 | 465 |
Repurchase of common stock | -572 | -559 |
Payment of dividends to stockholders | -1,119 | -1,114 |
Other financing | -200 | -307 |
Net cash used for financing activities | -1,650 | -1,738 |
Effect of exchange rate fluctuations on cash and cash equivalents | 1 | -10 |
Net increase (decrease) in cash and cash equivalents | -897 | -2,780 |
Cash and cash equivalents, end of period | 4,777 | 5,698 |
Cash paid during the period for: | ' | ' |
Income taxes, net of refunds | 571 | 200 |
Licensed Technology and Patents [Member] | ' | ' |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Amortization of intangibles | 68 | 66 |
Cash flows provided by (used for) investing activities: | ' | ' |
Purchases of licensed technology and patents | $0 | ($33) |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Mar. 29, 2014 | |
Basis of Presentation [Abstract] | ' |
Basis of Presentation [Text Block] | ' |
Note 1: Basis of Presentation | |
We prepared our interim consolidated condensed financial statements that accompany these notes in conformity with U.S. generally accepted accounting principles, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 28, 2013. We have reclassified certain prior period amounts to conform with current period presentation. | |
We have made estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, but reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 28, 2013. |
Fair_Value
Fair Value | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Fair Value [Abstract] | ' | ||||||||||||||||||||||||||||||||
Fair Value [Text Block] | ' | ||||||||||||||||||||||||||||||||
Note 2: Fair Value | |||||||||||||||||||||||||||||||||
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for equity method investments, cost method investments, cost method loans receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Most of our liabilities are not measured and recorded at fair value. | |||||||||||||||||||||||||||||||||
Fair Value Hierarchy | |||||||||||||||||||||||||||||||||
The three levels of inputs that may be used to measure fair value are as follows: | |||||||||||||||||||||||||||||||||
Level 1. Quoted prices in active markets for identical assets or liabilities. | |||||||||||||||||||||||||||||||||
Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions. | |||||||||||||||||||||||||||||||||
Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data. | |||||||||||||||||||||||||||||||||
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis | |||||||||||||||||||||||||||||||||
Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | 28-Dec-13 | ||||||||||||||||||||||||||||||||
Fair Value Measured and Recorded at Reporting Date Using | Fair Value Measured and Recorded at Reporting Date Using | ||||||||||||||||||||||||||||||||
(In Millions) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Corporate debt | $ | 154 | $ | 1,855 | $ | — | $ | 2,009 | $ | 154 | $ | 1,920 | $ | — | $ | 2,074 | |||||||||||||||||
Financial institution instruments | 173 | 1,763 | — | 1,936 | 887 | 1,190 | — | 2,077 | |||||||||||||||||||||||||
Government debt | — | 125 | — | 125 | — | 269 | — | 269 | |||||||||||||||||||||||||
Reverse repurchase agreements | — | 150 | — | 150 | — | 400 | — | 400 | |||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate debt | 269 | 1,250 | 19 | 1,538 | 274 | 1,374 | 19 | 1,667 | |||||||||||||||||||||||||
Financial institution instruments | 167 | 2,315 | — | 2,482 | 194 | 2,895 | — | 3,089 | |||||||||||||||||||||||||
Government debt | 368 | 846 | — | 1,214 | 183 | 1,033 | — | 1,216 | |||||||||||||||||||||||||
Trading assets: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 757 | 26 | 783 | — | 684 | 4 | 688 | |||||||||||||||||||||||||
Corporate debt | 2,450 | 635 | — | 3,085 | 2,161 | 628 | — | 2,789 | |||||||||||||||||||||||||
Financial institution instruments | 1,194 | 450 | — | 1,644 | 1,188 | 418 | — | 1,606 | |||||||||||||||||||||||||
Government debt | 1,638 | 1,885 | — | 3,523 | 1,625 | 1,733 | — | 3,358 | |||||||||||||||||||||||||
Other current assets: | |||||||||||||||||||||||||||||||||
Derivative assets | 12 | 230 | — | 242 | 48 | 309 | — | 357 | |||||||||||||||||||||||||
Loans receivable | — | 257 | — | 257 | — | 103 | — | 103 | |||||||||||||||||||||||||
Marketable equity securities | 6,085 | — | — | 6,085 | 6,221 | — | — | 6,221 | |||||||||||||||||||||||||
Other long-term investments: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | — | 9 | 9 | — | — | 9 | 9 | |||||||||||||||||||||||||
Corporate debt | 463 | 458 | 27 | 948 | 228 | 270 | 27 | 525 | |||||||||||||||||||||||||
Financial institution instruments | 131 | 330 | — | 461 | 90 | 402 | — | 492 | |||||||||||||||||||||||||
Government debt | 168 | 179 | — | 347 | 259 | 188 | — | 447 | |||||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 5 | 30 | 35 | — | 7 | 29 | 36 | |||||||||||||||||||||||||
Loans receivable | — | 556 | — | 556 | — | 702 | — | 702 | |||||||||||||||||||||||||
Total assets measured and recorded at fair value | $ | 13,272 | $ | 14,046 | $ | 111 | $ | 27,429 | $ | 13,512 | $ | 14,525 | $ | 88 | $ | 28,125 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||
Other accrued liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | $ | 7 | $ | 355 | $ | — | $ | 362 | $ | — | $ | 372 | $ | — | $ | 372 | |||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 47 | — | 47 | — | 50 | — | 50 | |||||||||||||||||||||||||
Total liabilities measured and recorded at fair value | $ | 7 | $ | 402 | $ | — | $ | 409 | $ | — | $ | 422 | $ | — | $ | 422 | |||||||||||||||||
Government debt includes instruments such as non-U.S. government bonds, U.S. agency securities, and U.S. Treasury securities. Financial institution instruments include instruments such as bank deposits, commercial paper, floating and fixed rate bonds, and money market funds. | |||||||||||||||||||||||||||||||||
During the first three months of 2014, we transferred approximately $230 million of corporate debt, government debt, and financial institution instruments from Level 2 to Level 1 of the fair value hierarchy, primarily based on greater market activity for the underlying securities. Our policy is to reflect transfers between the fair value hierarchy levels at the beginning of the quarter in which a change in circumstances resulted in the transfer. | |||||||||||||||||||||||||||||||||
Investments in Debt Instruments | |||||||||||||||||||||||||||||||||
Debt instruments reflected in the preceding table include investments such as asset-backed securities, corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. We classify our debt instruments as Level 2 when we use observable market prices for identical securities that are traded in less active markets. When observable market prices for identical securities are not available, we price the debt investments using our own models, such as a discounted cash flow model, or non-binding market consensus prices based on the proprietary valuation models of pricing providers or brokers. We corroborate non-binding market consensus prices with observable market data using statistical models when observable market data exists, quoted market prices for similar instruments, or pricing models such as a discounted cash flow model. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar securities; and the internal assumptions of pricing providers or brokers that use observable market inputs and unobservable market inputs that we consider to be not significant. The discounted cash flow model uses observable market inputs, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. All significant inputs are derived from or corroborated with observable market data. | |||||||||||||||||||||||||||||||||
Debt instruments classified as Level 3, are classified as such because the fair values are generally derived from discounted cash flow models, performed either by us or our pricing providers, using inputs that we are unable to corroborate with observable market data. We monitor and review the inputs and results of these valuation models to ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. | |||||||||||||||||||||||||||||||||
Fair Value Option for Loans Receivable | |||||||||||||||||||||||||||||||||
We elected the fair value option for loans receivable when the interest rate or currency exchange rate risk was hedged at inception with a related derivative instrument. As of March 29, 2014, the fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. Loans receivable are classified within other current assets and other long-term assets. Fair value is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Gains and losses from changes in fair value on the loans receivable and related derivative instruments, as well as interest income, are recorded in interest and other, net. During all periods presented, changes in the fair value of our loans receivable were largely offset by changes in the related derivative instruments, resulting in an insignificant net impact on our consolidated condensed statements of income. Gains and losses attributable to changes in credit risk are determined using observable credit default spreads for the issuer or comparable companies; these gains and losses were insignificant during all periods presented. We did not elect the fair value option for loans receivable when the interest rate or currency exchange rate risk was not hedged at inception with a related derivative instrument. Loans receivable not measured and recorded at fair value are included in the "Financial Instruments Not Recorded at Fair Value on a Recurring Basis" section that follows. | |||||||||||||||||||||||||||||||||
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis | |||||||||||||||||||||||||||||||||
Our non-marketable equity investments, marketable equity method investments, and non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment charge is recognized. | |||||||||||||||||||||||||||||||||
Some of our non-marketable equity investments have been measured and recorded at fair value due to events or circumstances that significantly impacted the fair value of those investments, resulting in other-than-temporary impairment charges. We classified these investments as Level 3 because the valuations used unobservable inputs that were significant to the fair value measurements and required management judgment due to the absence of quoted market prices. Impairment charges recognized on non-marketable equity investments held as of March 29, 2014, were $38 million during the first three months of 2014 ($14 million during the first three months of 2013 on non-marketable equity investments held as of March 30, 2013). | |||||||||||||||||||||||||||||||||
Financial Instruments Not Recorded at Fair Value on a Recurring Basis | |||||||||||||||||||||||||||||||||
On a quarterly basis, we measure the fair value of our grants receivable, cost method loans receivable, non-marketable cost method investments, reverse repurchase agreements with original maturities greater than approximately three months, and indebtedness carried at amortized cost; however, the assets are recorded at fair value only when an impairment charge is recognized. The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 569 | $ | — | $ | 576 | $ | — | $ | 576 | |||||||||||||||||||||||
Loans receivable | $ | 259 | $ | — | $ | 250 | $ | 9 | $ | 259 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,285 | $ | — | $ | — | $ | 2,120 | $ | 2,120 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 432 | $ | — | $ | 432 | $ | — | $ | 432 | |||||||||||||||||||||||
Short-term debt | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||
Long-term debt | $ | 13,172 | $ | 11,224 | $ | 2,714 | $ | — | $ | 13,938 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 389 | $ | — | $ | 397 | $ | — | $ | 397 | |||||||||||||||||||||||
28-Dec-13 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 416 | $ | — | $ | 481 | $ | — | $ | 481 | |||||||||||||||||||||||
Loans receivable | $ | 267 | $ | — | $ | 250 | $ | 17 | $ | 267 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,270 | $ | — | $ | — | $ | 2,105 | $ | 2,105 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 400 | $ | — | $ | 400 | $ | — | $ | 400 | |||||||||||||||||||||||
Short-term debt | $ | 24 | $ | — | $ | 24 | $ | — | $ | 24 | |||||||||||||||||||||||
Long-term debt | $ | 13,165 | $ | 10,937 | $ | 2,601 | $ | — | $ | 13,538 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 587 | $ | — | $ | 597 | $ | — | $ | 597 | |||||||||||||||||||||||
The fair value of our grants receivable is determined using a discounted cash flow model, which discounts future cash flows using an appropriate yield curve. As of March 29, 2014 and December 28, 2013, the carrying amount of our grants receivable was classified within other current assets and other long-term assets, as applicable. | |||||||||||||||||||||||||||||||||
The carrying amount and fair value of loans receivable exclude loans measured and recorded at a fair value of $813 million as of March 29, 2014 ($805 million as of December 28, 2013). The fair value of our loans receivable and reverse repurchase agreements, including those held at fair value, is determined using a discounted cash flow model. All significant inputs in the models are derived from or corroborated with observable market data, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. The credit quality of these assets remains high, with credit ratings of A+/A1 or better for a substantial majority of our loans receivable and reverse repurchase agreements as of March 29, 2014. | |||||||||||||||||||||||||||||||||
As of March 29, 2014 and December 28, 2013, the unrealized loss position of our non-marketable cost method investments was insignificant. Our non-marketable cost method investments are valued using the market and income approaches. The market approach includes the use of financial metrics and ratios of comparable public companies. The selection of comparable companies requires management judgment and is based on a number of factors, including comparable companies’ sizes, growth rates, industries, and development stages. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding investees’ revenue, costs, and discount rates based on the risk profile of comparable companies. Estimates of revenue and costs are developed using available market, historical, and forecast data. The valuation of these non-marketable cost method investments also takes into account variables such as conditions reflected in the capital markets, recent financing activities by the investees, the investees’ capital structure, the terms of the investees’ issued interests, and the lack of marketability of the investments. | |||||||||||||||||||||||||||||||||
The carrying amount and fair value of short-term debt exclude drafts payable. | |||||||||||||||||||||||||||||||||
Our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures. The fair value of our senior notes is determined using active market prices, and is therefore classified as Level 1. The fair value of our convertible debentures is determined using discounted cash flow models with observable market inputs, and takes into consideration variables such as interest rate changes, comparable securities, subordination discount, and credit-rating changes, and is therefore classified as Level 2. | |||||||||||||||||||||||||||||||||
The NVIDIA Corporation (NVIDIA) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with NVIDIA in January 2011. We agreed to make payments to NVIDIA over six years. As of March 29, 2014 and December 28, 2013, the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities, as applicable. The fair value is determined using a discounted cash flow model, which discounts future cash flows using our incremental borrowing rates. |
Cash_and_Investments
Cash and Investments | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Cash and Investments [Abstract] | ' | ||||||||||||||||||||||||||||||||
Cash And Investments [Text Block] | ' | ||||||||||||||||||||||||||||||||
Note 3: Cash and Investments | |||||||||||||||||||||||||||||||||
Cash and investments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Available-for-sale investments | $ | 17,154 | $ | 18,086 | |||||||||||||||||||||||||||||
Cash | 557 | 854 | |||||||||||||||||||||||||||||||
Equity method investments | 1,107 | 1,038 | |||||||||||||||||||||||||||||||
Loans receivable | 1,072 | 1,072 | |||||||||||||||||||||||||||||||
Non-marketable cost method investments | 1,285 | 1,270 | |||||||||||||||||||||||||||||||
Reverse repurchase agreements | 582 | 800 | |||||||||||||||||||||||||||||||
Trading assets | 9,035 | 8,441 | |||||||||||||||||||||||||||||||
Total cash and investments | $ | 30,792 | $ | 31,561 | |||||||||||||||||||||||||||||
Available-for-Sale Investments | |||||||||||||||||||||||||||||||||
Available-for-sale investments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | 28-Dec-13 | ||||||||||||||||||||||||||||||||
(In Millions) | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||
Asset-backed securities | $ | 10 | $ | 1 | $ | (2 | ) | $ | 9 | $ | 11 | $ | — | $ | (2 | ) | $ | 9 | |||||||||||||||
Corporate debt | 4,482 | 15 | (2 | ) | 4,495 | 4,254 | 15 | (3 | ) | 4,266 | |||||||||||||||||||||||
Financial institution instruments | 4,874 | 6 | (1 | ) | 4,879 | 5,654 | 5 | (1 | ) | 5,658 | |||||||||||||||||||||||
Government debt | 1,686 | — | — | 1,686 | 1,932 | 1 | (1 | ) | 1,932 | ||||||||||||||||||||||||
Marketable equity securities | 3,321 | 2,764 | — | 6,085 | 3,340 | 2,881 | — | 6,221 | |||||||||||||||||||||||||
Total available-for-sale investments | $ | 14,373 | $ | 2,786 | $ | (5 | ) | $ | 17,154 | $ | 15,191 | $ | 2,902 | $ | (7 | ) | $ | 18,086 | |||||||||||||||
Government debt includes instruments such as non-U.S. government bonds, U.S. agency securities, and U.S. Treasury securities. Financial institution instruments include instruments such as bank deposits, commercial paper, floating and fixed rate bonds, and money market funds. Bank deposits were primarily issued by institutions outside the U.S. as of March 29, 2014 and December 28, 2013. | |||||||||||||||||||||||||||||||||
For information on the unrealized holding gains (losses) on available-for-sale investments reclassified out of accumulated other comprehensive income into the consolidated condensed statements of income, see "Note 18: Other Comprehensive Income (Loss)". | |||||||||||||||||||||||||||||||||
We sold available-for-sale investments for proceeds of $174 million in the first three months of 2014 ($304 million in the first three months of 2013). The gross realized gains on sales of available-for-sale investments were $67 million in the first three months of 2014. | |||||||||||||||||||||||||||||||||
The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of March 29, 2014, were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 8,703 | $ | 8,722 | |||||||||||||||||||||||||||||
Due in 1–2 years | 1,007 | 1,006 | |||||||||||||||||||||||||||||||
Due in 2–5 years | 750 | 751 | |||||||||||||||||||||||||||||||
Instruments not due at a single maturity date | 592 | 590 | |||||||||||||||||||||||||||||||
Total | $ | 11,052 | $ | 11,069 | |||||||||||||||||||||||||||||
Instruments not due at a single maturity date in the preceding table primarily include government debt and corporate debt. | |||||||||||||||||||||||||||||||||
Equity Method Investments | |||||||||||||||||||||||||||||||||
IM Flash Technologies, LLC | |||||||||||||||||||||||||||||||||
Micron Technology, Inc. (Micron) and Intel formed IM Flash Technologies, LLC (IMFT) in 2007 to manufacture NAND flash memory products for Micron and Intel. During 2012, we amended the operating agreement for IMFT and entered into agreements with Micron that modified our joint venture relationship. The amended operating agreement extended the term of IMFT to 2024, unless earlier terminated under certain terms and conditions, and provides that IMFT may manufacture certain emerging memory technologies in addition to NAND flash memory. Additionally, the amended agreement provides for certain rights that, beginning in 2015, will enable us to sell to Micron, or enable Micron to purchase from us, our interest in IMFT. If Intel exercises this right, Micron would set the closing date of the transaction within two years following such election and could elect to receive financing from Intel for one to two years. The agreements with Micron include a supply agreement for Micron to supply us with NAND flash memory products. The agreements also extend and expand our NAND joint development program with Micron to include emerging memory technologies. | |||||||||||||||||||||||||||||||||
As of March 29, 2014, we own a 49% interest in IMFT. The carrying value of our investment was $656 million as of March 29, 2014 ($646 million as of December 28, 2013) and is classified within other long-term assets. | |||||||||||||||||||||||||||||||||
IMFT is a variable interest entity. All costs of the IMFT joint venture will be passed on to Micron and Intel pursuant to our purchase agreements. Intel's portion of IMFT costs, primarily related to product purchases and production-related services, was approximately $105 million during the first three months of 2014 (approximately $100 million during the first three months of 2013). The amount due to IMFT for product purchases and services provided was approximately $100 million as of March 29, 2014 (approximately $75 million as of December 28, 2013). | |||||||||||||||||||||||||||||||||
IMFT depends on Micron and Intel for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in IMFT, which was $656 million as of March 29, 2014. Except for the amount due to IMFT for product purchases and services, we did not have any additional liabilities recognized on our consolidated condensed balance sheets in connection with our interests in this joint venture as of March 29, 2014. Our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT. Future cash calls could also increase our investment balance and the related exposure to loss. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value. | |||||||||||||||||||||||||||||||||
We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in IMFT using the equity method of accounting. | |||||||||||||||||||||||||||||||||
Trading Assets | |||||||||||||||||||||||||||||||||
As of March 29, 2014 and December 28, 2013, all of our trading assets were marketable debt instruments. Net gains related to trading assets still held at the reporting date were $79 million in the first three months of 2014 (net losses of $163 million in the first three months of 2013). Net losses on the related derivatives were $82 million in the first three months of 2014 (net gains of $164 million in the first three months of 2013). |
Inventories
Inventories | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Inventory, Net [Abstract] | ' | ||||||||
Inventories [Text Block] | ' | ||||||||
Note 4: Inventories | |||||||||
We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development are included in cost of sales in the period incurred. Inventories at the end of each period were as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Raw materials | $ | 463 | $ | 458 | |||||
Work in process | 1,803 | 1,998 | |||||||
Finished goods | 1,497 | 1,716 | |||||||
Total inventories | $ | 3,763 | $ | 4,172 | |||||
Derivative_Financial_Instrumen
Derivative Financial Instruments | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||||||||||||||
Derivative Financial Instruments [Text Block] | ' | ||||||||||||||||||||||||||||||||
Note 5: Derivative Financial Instruments | |||||||||||||||||||||||||||||||||
Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. We also enter into master netting arrangements with counterparties when possible to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated condensed balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. | |||||||||||||||||||||||||||||||||
Currency Exchange Rate Risk | |||||||||||||||||||||||||||||||||
We are exposed to currency exchange rate risk and generally hedge our exposures with currency forward contracts, currency interest rate swaps, or currency options. Substantially all of our revenue is transacted in U.S. dollars. However, a significant amount of our operating expenditures and capital purchases is incurred in or exposed to other currencies, primarily the euro, the Japanese yen, the Israeli shekel, and the Chinese yuan. We have established balance sheet and forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of the functional currency equivalent of future cash flows caused by changes in exchange rates. Our non-U.S.-dollar-denominated investments in debt instruments and loans receivable are generally hedged with offsetting currency forward contracts or currency interest rate swaps. We may also hedge currency risk arising from funding foreign currency denominated forecasted investments. These programs reduce, but do not eliminate, the impact of currency exchange movements. | |||||||||||||||||||||||||||||||||
Our currency risk management programs include: | |||||||||||||||||||||||||||||||||
• | Currency derivatives with cash flow hedge accounting designation that utilize currency forward contracts and currency options to hedge exposures to the variability in the U.S.-dollar equivalent of anticipated non-U.S.-dollar-denominated cash flows. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated condensed statements of income as the impact of the hedged transaction. | ||||||||||||||||||||||||||||||||
• | Currency derivatives without hedge accounting designation that utilize currency forward contracts or currency interest rate swaps to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. The majority of these instruments mature within 12 months. Changes in the functional currency equivalent cash flows of the underlying assets and liabilities are approximately offset by the changes in fair value of the related derivatives. We record net gains or losses in the line item on the consolidated condensed statements of income most closely associated with the related exposures, primarily in interest and other, net, except for equity-related gains or losses, which we primarily record in gains (losses) on equity investments, net. | ||||||||||||||||||||||||||||||||
Interest Rate Risk | |||||||||||||||||||||||||||||||||
Our primary objective for holding investments in debt instruments is to preserve principal while maximizing yields. We generally swap the returns on our investments in fixed-rate debt instruments with remaining maturities longer than six months into U.S. dollar three-month LIBOR-based returns, unless management specifically approves otherwise. These swaps are settled at various interest payment times involving cash payments at each interest and principal payment date, with the majority of the contracts having quarterly payments. | |||||||||||||||||||||||||||||||||
Our interest rate risk management programs include: | |||||||||||||||||||||||||||||||||
• | Interest rate derivatives with cash flow hedge accounting designation that utilize interest rate swap agreements to modify the interest characteristics of debt instruments. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated condensed statements of income as the impact of the hedged transaction. | ||||||||||||||||||||||||||||||||
• | Interest rate derivatives without hedge accounting designation that utilize interest rate swaps and currency interest rate swaps in economic hedging transactions, including hedges of non-U.S.-dollar-denominated debt instruments classified as trading assets and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. Floating interest rates on the swaps are reset on a quarterly basis. Changes in fair value of the debt instruments classified as trading assets and loans receivable recognized at fair value are generally offset by changes in fair value of the related derivatives, both of which are recorded in interest and other, net. | ||||||||||||||||||||||||||||||||
Equity Market Risk | |||||||||||||||||||||||||||||||||
Our investments include marketable equity securities and equity derivative instruments. We typically do not attempt to reduce or eliminate our equity market exposure through hedging activities at the inception of the investment. Before we enter into hedge arrangements, we evaluate legal, market, and economic factors, as well as the expected timing of disposal to determine whether hedging is appropriate. Our equity market risk management program may include equity derivatives with or without hedge accounting designation that utilize warrants, equity options, or other equity derivatives. We recognize changes in the fair value of such derivatives in gains (losses) on equity investments, net. We also utilize total return swaps to offset changes in liabilities related to the equity market risks of certain deferred compensation arrangements. Gains and losses from changes in fair value of these total return swaps are generally offset by the losses and gains on the related liabilities, both of which are recorded in cost of sales and operating expenses. | |||||||||||||||||||||||||||||||||
Commodity Price Risk | |||||||||||||||||||||||||||||||||
We operate facilities that consume commodities, and have established forecasted transaction risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in commodity prices, such as those for natural gas. These programs reduce, but do not always eliminate, the impact of commodity price movements. | |||||||||||||||||||||||||||||||||
Our commodity price risk management program includes commodity derivatives with cash flow hedge accounting designation that utilize commodity swap contracts to hedge future cash flow exposures to the variability in commodity prices. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated condensed statements of income as the impact of the hedged transaction. | |||||||||||||||||||||||||||||||||
Volume of Derivative Activity | |||||||||||||||||||||||||||||||||
Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Dec 28, | Mar 30, | ||||||||||||||||||||||||||||||
2014 | 2013 | 2013 | |||||||||||||||||||||||||||||||
Currency forwards | $ | 11,729 | $ | 13,404 | $ | 13,141 | |||||||||||||||||||||||||||
Currency interest rate swaps | 4,795 | 4,377 | 3,464 | ||||||||||||||||||||||||||||||
Embedded debt derivatives | 3,600 | 3,600 | 3,600 | ||||||||||||||||||||||||||||||
Interest rate swaps | 1,311 | 1,377 | 1,041 | ||||||||||||||||||||||||||||||
Total return swaps | 989 | 914 | 859 | ||||||||||||||||||||||||||||||
Other | 60 | 67 | 82 | ||||||||||||||||||||||||||||||
Total | $ | 22,484 | $ | 23,739 | $ | 22,187 | |||||||||||||||||||||||||||
The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Dec 28, | Mar 30, | ||||||||||||||||||||||||||||||
2014 | 2013 | 2013 | |||||||||||||||||||||||||||||||
British pound sterling | $ | 487 | $ | 549 | $ | 422 | |||||||||||||||||||||||||||
Chinese yuan | 1,291 | 1,116 | 572 | ||||||||||||||||||||||||||||||
Euro | 6,199 | 6,874 | 6,800 | ||||||||||||||||||||||||||||||
Israeli shekel | 1,878 | 2,244 | 1,974 | ||||||||||||||||||||||||||||||
Japanese yen | 3,542 | 4,116 | 3,854 | ||||||||||||||||||||||||||||||
Malaysian ringgit | 524 | 506 | 520 | ||||||||||||||||||||||||||||||
Swiss franc | 1,256 | 1,189 | 1,312 | ||||||||||||||||||||||||||||||
Other | 1,347 | 1,187 | 1,151 | ||||||||||||||||||||||||||||||
Total | $ | 16,524 | $ | 17,781 | $ | 16,605 | |||||||||||||||||||||||||||
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets | |||||||||||||||||||||||||||||||||
The fair value of our derivative instruments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
March 29, 2014 | December 28, 2013 | ||||||||||||||||||||||||||||||||
(In Millions) | Other | Other | Other | Other | Other | Other | Other | Other | |||||||||||||||||||||||||
Current | Long-Term | Accrued | Long-Term | Current | Long-Term | Accrued | Long-Term | ||||||||||||||||||||||||||
Assets | Assets | Liabilities | Liabilities | Assets | Assets | Liabilities | Liabilities | ||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 86 | $ | — | $ | 53 | $ | 1 | $ | 114 | $ | 1 | $ | 118 | $ | 2 | |||||||||||||||||
Other | — | — | 3 | — | — | — | — | — | |||||||||||||||||||||||||
Total derivatives designated as hedging instruments | $ | 86 | $ | — | $ | 56 | $ | 1 | $ | 114 | $ | 1 | $ | 118 | $ | 2 | |||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 36 | $ | — | $ | 80 | $ | — | $ | 66 | $ | — | $ | 63 | $ | — | |||||||||||||||||
Currency interest rate swaps | 104 | 5 | 197 | 32 | 124 | 6 | 163 | 29 | |||||||||||||||||||||||||
Embedded debt derivatives | — | — | — | 14 | — | — | — | 19 | |||||||||||||||||||||||||
Interest rate swaps | 4 | — | 22 | — | 5 | — | 28 | — | |||||||||||||||||||||||||
Total return swaps | 12 | — | 7 | — | 48 | — | — | — | |||||||||||||||||||||||||
Other | — | 30 | — | — | — | 29 | — | — | |||||||||||||||||||||||||
Total derivatives not designated as hedging instruments | $ | 156 | $ | 35 | $ | 306 | $ | 46 | $ | 243 | $ | 35 | $ | 254 | $ | 48 | |||||||||||||||||
Total derivatives | $ | 242 | $ | 35 | $ | 362 | $ | 47 | $ | 357 | $ | 36 | $ | 372 | $ | 50 | |||||||||||||||||
Amounts Offset in the Consolidated Condensed Balance Sheets | |||||||||||||||||||||||||||||||||
The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties and cash and non-cash collateral posted under such agreements at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 221 | $ | — | $ | 221 | $ | (158 | ) | $ | (9 | ) | $ | 54 | |||||||||||||||||||
Reverse repurchase agreements | 582 | — | 582 | — | (582 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 803 | $ | — | $ | 803 | $ | (158 | ) | $ | (591 | ) | $ | 54 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 391 | $ | — | $ | 391 | $ | (158 | ) | $ | (181 | ) | $ | 52 | |||||||||||||||||||
Total liabilities | $ | 391 | $ | — | $ | 391 | $ | (158 | ) | $ | (181 | ) | $ | 52 | |||||||||||||||||||
28-Dec-13 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 325 | $ | — | $ | 325 | $ | (158 | ) | $ | (3 | ) | $ | 164 | |||||||||||||||||||
Reverse repurchase agreements | 800 | — | 800 | — | (800 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,125 | $ | — | $ | 1,125 | $ | (158 | ) | $ | (803 | ) | $ | 164 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 401 | $ | — | $ | 401 | $ | (158 | ) | $ | (32 | ) | $ | 211 | |||||||||||||||||||
Total liabilities | $ | 401 | $ | — | $ | 401 | $ | (158 | ) | $ | (32 | ) | $ | 211 | |||||||||||||||||||
Derivatives in Cash Flow Hedging Relationships | |||||||||||||||||||||||||||||||||
The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Currency forwards | $ | 35 | $ | (236 | ) | ||||||||||||||||||||||||||||
Other | (2 | ) | 1 | ||||||||||||||||||||||||||||||
Total | $ | 33 | $ | (235 | ) | ||||||||||||||||||||||||||||
Gains and losses on derivative instruments in cash flow hedging relationships related to hedge ineffectiveness and amounts excluded from effectiveness testing, were insignificant during all periods presented in the preceding tables. Additionally, for all periods presented, there was an insignificant impact on results of operations from discontinued cash flow hedges, which arises when forecasted transactions are probable of not occurring. | |||||||||||||||||||||||||||||||||
For information on the unrealized holding gains (losses) on derivatives reclassified out of accumulated other comprehensive income into the consolidated condensed statements of income, see "Note 18: Other Comprehensive Income (Loss)." | |||||||||||||||||||||||||||||||||
Derivatives Not Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||
The effects of derivative instruments not designated as hedging instruments on the consolidated condensed statements of income for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Location of Gains (Losses) | Mar 29, | Mar 30, | ||||||||||||||||||||||||||||||
Recognized in Income on Derivatives | 2014 | 2013 | |||||||||||||||||||||||||||||||
Currency forwards | Interest and other, net | $ | (15 | ) | $ | 56 | |||||||||||||||||||||||||||
Currency interest rate swaps | Interest and other, net | (54 | ) | 100 | |||||||||||||||||||||||||||||
Total return swaps | Various | 13 | 48 | ||||||||||||||||||||||||||||||
Other | Gains (losses) on equity investments, net | 1 | 2 | ||||||||||||||||||||||||||||||
Total | $ | (55 | ) | $ | 206 | ||||||||||||||||||||||||||||
Acquisitions
Acquisitions | 3 Months Ended |
Mar. 29, 2014 | |
Acquisitions [Abstract] | ' |
Acquisitions [Text Block] | ' |
Note 6: Acquisitions | |
During the first three months of 2014, we completed two acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $108 million, most of which was allocated to goodwill. See “Note 8: Goodwill” for information on the assignment of goodwill to our operating segments. The completed acquisitions in the first three months of 2014, both individually and in the aggregate, were not significant to our results of operations. |
Divestitures
Divestitures | 3 Months Ended |
Mar. 29, 2014 | |
Divestitures [Abstract] | ' |
Divestitures [Text Block] | ' |
Note 7: Divestitures | |
During the first quarter of 2014, we completed the divestiture of our Intel Media assets, a business division dedicated to the development of cloud TV products and services, to Verizon Communications Inc. As a result of the transaction, we received aggregate net cash consideration of $150 million, presented within investing activities on the consolidated condensed statements of cash flows, and recognized a gain within interest and other, net on the consolidated condensed statements of income. |
Goodwill
Goodwill | 3 Months Ended | ||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||
Goodwill [Abstract] | ' | ||||||||||||||||||||
Goodwill [Text Block] | ' | ||||||||||||||||||||
Note 8: Goodwill | |||||||||||||||||||||
Goodwill activity for the first three months of 2014 was as follows: | |||||||||||||||||||||
(In Millions) | Dec 28, | Additions Due to Acquisitions | Transfers | Effect of Exchange Rate Fluctuations and Other | Mar 29, | ||||||||||||||||
2013 | 2014 | ||||||||||||||||||||
PC Client Group | $ | 3,058 | $ | — | $ | — | $ | — | $ | 3,058 | |||||||||||
Data Center Group | 1,831 | 8 | 138 | — | 1,977 | ||||||||||||||||
Internet of Things Group | — | — | 428 | — | 428 | ||||||||||||||||
Mobile and Communications Group | — | — | 631 | — | 631 | ||||||||||||||||
Other Intel architecture operating segments | 1,075 | — | (1,075 | ) | — | — | |||||||||||||||
Software and services operating segments | 4,549 | — | (140 | ) | 23 | 4,432 | |||||||||||||||
All other | — | 91 | 18 | (18 | ) | 91 | |||||||||||||||
Total | $ | 10,513 | $ | 99 | $ | — | $ | 5 | $ | 10,617 | |||||||||||
In the first quarter of 2014, we formed the Internet of Things Group and we changed our organizational structure to align with our critical objectives, which included the addition of Mobile and Communication Group as a reportable operating segment. For further information see "Note 20: Operating Segments Information." Due to this reorganization, goodwill was allocated from our prior reporting units to our new reporting units, as shown in the preceding table within "transfers." The allocation was based on the fair value of each business group within its original reporting unit relative to the fair value of that reporting unit. |
Identified_Intangible_Assets
Identified Intangible Assets | 3 Months Ended | ||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | ||||||||||||||||||||
Identified Intangible Assets [Text Block] | ' | ||||||||||||||||||||
Note 9: Identified Intangible Assets | |||||||||||||||||||||
Identified intangible assets at the end of each period were as follows: | |||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,932 | $ | (1,841 | ) | $ | 1,091 | ||||||||||||||
Acquisition-related customer relationships | 1,766 | (901 | ) | 865 | |||||||||||||||||
Acquisition-related trade names | 65 | (47 | ) | 18 | |||||||||||||||||
Licensed technology and patents | 3,088 | (1,017 | ) | 2,071 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,851 | (3,806 | ) | 4,045 | |||||||||||||||||
Acquisition-related trade names | 821 | — | 821 | ||||||||||||||||||
Other intangible assets | 97 | — | 97 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 918 | — | 918 | ||||||||||||||||||
Total identified intangible assets | $ | 8,769 | $ | (3,806 | ) | $ | 4,963 | ||||||||||||||
December 28, 2013 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,922 | $ | (1,691 | ) | $ | 1,231 | ||||||||||||||
Acquisition-related customer relationships | 1,760 | (828 | ) | 932 | |||||||||||||||||
Acquisition-related trade names | 65 | (44 | ) | 21 | |||||||||||||||||
Licensed technology and patents | 3,093 | (974 | ) | 2,119 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,840 | (3,537 | ) | 4,303 | |||||||||||||||||
Acquisition-related trade names | 818 | — | 818 | ||||||||||||||||||
Other intangible assets | 29 | — | 29 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 847 | — | 847 | ||||||||||||||||||
Total identified intangible assets | $ | 8,687 | $ | (3,537 | ) | $ | 5,150 | ||||||||||||||
For identified intangible assets that are subject to amortization, we recorded amortization expense on the consolidated condensed statements of income as follows: amortization of acquisition-related developed technology and licensed technology and patents is included in cost of sales, amortization of acquisition-related customer relationships and trade names is included in amortization of acquisition-related intangibles, and amortization of other intangible assets is recorded as a reduction of revenue. | |||||||||||||||||||||
Amortization expenses for each period were as follows: | |||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
Acquisition-related developed technology | $ | 146 | $ | 140 | |||||||||||||||||
Acquisition-related customer relationships | 70 | 70 | |||||||||||||||||||
Acquisition-related trade names | 3 | 3 | |||||||||||||||||||
Licensed technology and patents | 68 | 66 | |||||||||||||||||||
Other intangible assets | — | 103 | |||||||||||||||||||
Total amortization expenses | $ | 287 | $ | 382 | |||||||||||||||||
Based on identified intangible assets that are subject to amortization as of March 29, 2014, we expect future amortization expenses for each period to be as follows: | |||||||||||||||||||||
(In Millions) | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | ||||||||||||||||
Acquisition-related developed technology | $ | 434 | $ | 303 | $ | 211 | $ | 63 | $ | 41 | |||||||||||
Acquisition-related customer relationships | 200 | 252 | 234 | 142 | 29 | ||||||||||||||||
Acquisition-related trade names | 7 | 8 | 3 | — | — | ||||||||||||||||
Licensed technology and patents | 203 | 254 | 239 | 200 | 159 | ||||||||||||||||
Total future amortization expenses | $ | 844 | $ | 817 | $ | 687 | $ | 405 | $ | 229 | |||||||||||
Other_LongTerm_Assets
Other Long-Term Assets | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Other Assets, Noncurrent Disclosure [Abstract] | ' | ||||||||
Other Long-Term Assets [Text Block] | ' | ||||||||
Note 10: Other Long-Term Assets | |||||||||
Other long-term assets at the end of each period were as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Equity method investments | $ | 1,107 | $ | 1,038 | |||||
Non-marketable cost method investments | 1,285 | 1,270 | |||||||
Non-current deferred tax assets | 449 | 434 | |||||||
Loans receivable | 806 | 952 | |||||||
Prepayments for property, plant and equipment | 457 | 521 | |||||||
Other | 1,342 | 1,274 | |||||||
Total other long-term assets | $ | 5,446 | $ | 5,489 | |||||
During the first three months of 2014, we received equipment that was prepaid in 2010 and 2011. Upon receipt of the equipment, we transferred $117 million from other long-term assets to property, plant and equipment. We recognized the prepayments within operating activities in the consolidated condensed statement of cash flows when we paid for the equipment in 2010 and 2011, and the receipt of the equipment is reflected as a non-cash transaction in the current period. |
Restructuring_and_Asset_Impair
Restructuring and Asset Impairment Charges | 3 Months Ended | ||||||||||||
Mar. 29, 2014 | |||||||||||||
Restructuring Costs and Asset Impairment Charges [Abstract] | ' | ||||||||||||
Restructuring And Asset Impairment Charges [Text Block] | ' | ||||||||||||
Note 11: Restructuring and Asset Impairment Charges | |||||||||||||
In response to the current business environment, beginning in the third quarter of 2013, management approved several restructuring actions including targeted workforce reductions as well as exit of certain businesses and facilities. These actions include the wind down of our 200 millimeter wafer fabrication facility in Massachusetts, which we expect to cease production by the end of 2014. These targeted reductions will enable the company to better align our resources in areas providing the greatest benefit in the changing market. | |||||||||||||
Restructuring and asset impairment charges for each period were as follows: | |||||||||||||
Three Months Ended | |||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||
2014 | 2013 | ||||||||||||
Employee severance and benefit arrangements | $ | 137 | $ | — | |||||||||
Asset impairments | — | — | |||||||||||
Total restructuring and asset impairment charges | $ | 137 | $ | — | |||||||||
The restructuring and asset impairment activity for first three months of 2014 was as follows: | |||||||||||||
(In Millions) | Employee Severance and Benefits | Asset Impairments | Total | ||||||||||
Accrued restructuring balance as of December 28, 2013 | $ | 183 | $ | — | $ | 183 | |||||||
Additional accruals | 139 | — | 139 | ||||||||||
Adjustments | (2 | ) | — | (2 | ) | ||||||||
Cash payments | (57 | ) | — | (57 | ) | ||||||||
Accrued restructuring balance as of March 29, 2014 | $ | 263 | $ | — | $ | 263 | |||||||
We recorded the additional accruals and adjustments as restructuring and asset impairment charges in the consolidated condensed statements of income and within the “all other” operating segments category. The charges incurred during the first three months of 2014 included $137 million related to employee severance and benefit arrangements, which impacted approximately 2,200 employees. The accrued restructuring balance as of March 29, 2014 relates to employee severance and benefits which are expected to be paid within the next 12 months and was recorded as a current liability within accrued compensation and benefits in the consolidated condensed balance sheets. | |||||||||||||
Since the third quarter of 2013, we have incurred a total of $377 million in restructuring and asset impairment charges. These charges included a total of $338 million related to employee severance and benefit arrangements for approximately 6,100 employees, and $39 million in asset impairment charges. | |||||||||||||
We may incur additional charges in the future for employee severance and benefit arrangements, as well as facility-related or other exit activities, as we continue to align our resources to meet the needs of the business. |
Deferred_Income
Deferred Income | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Deferred Income [Abstract] | ' | ||||||||
Deferred Income [Text Block] | ' | ||||||||
Note 12: Deferred Income | |||||||||
Deferred income at the end of each period was as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Deferred income on shipments of components to distributors | $ | 928 | $ | 852 | |||||
Deferred income from software and services operating segments | 1,243 | 1,244 | |||||||
Current deferred income | 2,171 | 2,096 | |||||||
Non-current deferred income from software and services operating segments | 482 | 506 | |||||||
Total deferred income | $ | 2,653 | $ | 2,602 | |||||
We classify non-current deferred income from the software and services operating segments in other long-term liabilities. |
Employee_Equity_Incentive_Plan
Employee Equity Incentive Plans | 3 Months Ended | |||||||
Mar. 29, 2014 | ||||||||
Employee Benefit And Share-Based Compensation [Abstract] | ' | |||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | ' | |||||||
Note 13: Employee Equity Incentive Plans | ||||||||
Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. | ||||||||
Under the 2006 Equity Incentive Plan (the 2006 Plan), 719 million shares of common stock are available for issuance as equity awards to employees and non-employee directors through June 2016. A maximum of 517 million of these shares can be awarded as non-vested shares (restricted stock) or non-vested share units (restricted stock units). As of March 29, 2014, 305 million shares remained available for future grant under the 2006 Plan. | ||||||||
The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. Rights to purchase shares are granted during the first and third quarters of each year. Under the 2006 Stock Purchase Plan, stockholders made 373 million shares of common stock available for issuance through August 2016. As of March 29, 2014, 206 million shares were available for issuance under the 2006 Stock Purchase Plan. | ||||||||
Restricted Stock Unit Awards | ||||||||
Information with respect to outstanding restricted stock unit (RSU) activity in the first three months of 2014 was as follows: | ||||||||
Number of | Weighted Average | |||||||
RSUs | Grant-Date | |||||||
(In Millions) | Fair Value | |||||||
December 28, 2013 | 113.3 | $ | 22.47 | |||||
Granted | 3.6 | $ | 26.28 | |||||
Vested | (3.1 | ) | $ | 23.06 | ||||
Forfeited | (2.7 | ) | $ | 22.44 | ||||
March 29, 2014 | 111.1 | $ | 22.58 | |||||
As of March 29, 2014, 3.2 million of the outstanding restricted stock units were market-based restricted stock units. | ||||||||
Stock Option Awards | ||||||||
Information with respect to outstanding stock option activity in the first three months of 2014 was as follows: | ||||||||
Number of | Weighted Average | |||||||
Options | Exercise Price | |||||||
(In Millions) | ||||||||
December 28, 2013 | 153 | $ | 21.1 | |||||
Granted | 0.5 | $ | 25.08 | |||||
Exercised | (13.9 | ) | $ | 19.26 | ||||
Cancelled and forfeited | (1.3 | ) | $ | 23.48 | ||||
Expired | (0.3 | ) | $ | 31.34 | ||||
March 29, 2014 | 138 | $ | 21.26 | |||||
Options exercisable as of: | ||||||||
December 28, 2013 | 111.5 | $ | 20.25 | |||||
March 29, 2014 | 102.3 | $ | 20.37 | |||||
Stock Purchase Plan | ||||||||
Employees purchased 10.7 million shares in the first three months of 2014 for $212 million (11.1 million shares in the first three months of 2013 for $200 million) under the 2006 Stock Purchase Plan. |
Common_Stock_Repurchases
Common Stock Repurchases | 3 Months Ended |
Mar. 29, 2014 | |
Common Stock Repurchases [Abstract] | ' |
Common Stock Repurchases [Text Block] | ' |
Note 14: Common Stock Repurchases | |
Common Stock Repurchase Program | |
We have an ongoing authorization, originally approved by our Board of Directors in October 2005, and subsequently amended, to repurchase up to $45 billion in shares of our common stock in open market or negotiated transactions. As of March 29, 2014, $2.6 billion remained available for repurchase under the existing repurchase authorization limit. During the first three months of 2014, we repurchased 22.1 million shares of common stock at a cost of $545 million (25.2 million shares of common stock at a cost of $533 million during the first three months of 2013). We have repurchased 4.4 billion shares at a cost of $92 billion since the program began in 1990. |
Gains_Losses_on_Equity_Investm
Gains (Losses) on Equity Investments, Net | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Gains (Losses) on Equity Investments, Net [Abstract] | ' | ||||||||
Gains (Losses) on Equity Investments, Net [Text Block] | ' | ||||||||
Note 15: Gains (Losses) on Equity Investments, Net | |||||||||
The components of gains (losses) on equity investments, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Share of equity method investee losses, net | $ | (11 | ) | $ | (23 | ) | |||
Impairment charges | (38 | ) | (17 | ) | |||||
Gains on sales, net | 71 | 4 | |||||||
Other, net | 26 | 10 | |||||||
Total gains (losses) on equity investments, net | $ | 48 | $ | (26 | ) | ||||
Interest_and_Other_Net
Interest and Other, Net | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Interest and Other, Net [Abstract] | ' | ||||||||
Interest and Other, Net [Text Block] | ' | ||||||||
Note 16: Interest and Other, Net | |||||||||
The components of interest and other, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Interest income | $ | 35 | $ | 23 | |||||
Interest expense | (37 | ) | (73 | ) | |||||
Other, net | 114 | — | |||||||
Total interest and other, net | $ | 112 | $ | (50 | ) | ||||
Interest expense in the preceding table is net of $77 million of interest capitalized in the first three months of 2014 ($54 million in the first three months of 2013). | |||||||||
During the first quarter of 2014, we completed the divestiture of our Intel Media assets. As a result of the transaction, we recognized a gain within "other, net" in the preceding table. For further information, see "Note 7: Divestitures." |
Earnings_Per_Share
Earnings Per Share | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Earnings Per Share [Text Block] | ' | ||||||||
Note 17: Earnings Per Share | |||||||||
We computed our basic and diluted earnings per common share for each period as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions, Except Per Share Amounts) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Net income available to common stockholders | $ | 1,930 | $ | 2,045 | |||||
Weighted average common shares outstanding—basic | 4,974 | 4,948 | |||||||
Dilutive effect of employee equity incentive plans | 76 | 78 | |||||||
Dilutive effect of convertible debt | 67 | 54 | |||||||
Weighted average common shares outstanding—diluted | 5,117 | 5,080 | |||||||
Basic earnings per common share | $ | 0.39 | $ | 0.41 | |||||
Diluted earnings per common share | $ | 0.38 | $ | 0.4 | |||||
We computed basic earnings per common share using net income available to common stockholders and the weighted average number of common shares outstanding during the period. We computed diluted earnings per common share using net income available to common stockholders and the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period. Net income available to participating securities was insignificant for all periods presented. | |||||||||
Potentially dilutive common shares from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive common shares are determined by applying the if-converted method for our 2005 junior subordinated convertible debentures. However, as our 2009 junior subordinated convertible debentures (2009 debentures) require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive common shares are determined by applying the treasury stock method. | |||||||||
During the first three months of 2014, we excluded 33 million outstanding stock options and restricted stock units from the computation of diluted earnings per common share because these would have been antidilutive (62 million for the first three months of 2013). These options could potentially be included in the diluted earnings per common share calculation in the future if the average market value of the common shares increases and is greater than the exercise price of these options. | |||||||||
In the first three months of 2014, we included our 2009 debentures in the calculation of diluted earnings per common share because the average market price was above the conversion price. In the first three months of 2013, we excluded the 2009 debentures from the calculation of diluted earnings per common share because these would have been antidilutive. We could potentially exclude the 2009 debentures again in the future if the average market price is below the conversion price. |
Other_Comprehensive_Income_Los
Other Comprehensive Income (Loss) | 3 Months Ended | ||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||
Comprehensive Income (Loss) [Abstract] | ' | ||||||||||||||||||||||||||||
Comprehensive Income [Text Block] | ' | ||||||||||||||||||||||||||||
Note 18: Other Comprehensive Income (Loss) | |||||||||||||||||||||||||||||
The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2014 were as follows: | |||||||||||||||||||||||||||||
(In Millions) | Unrealized Holding Gains (Losses) on Available-for-Sale Investments | Deferred Tax Asset Valuation Allowance | Unrealized Holding Gains (Losses) on Derivatives | Prior Service Credits (Costs) | Actuarial Gains (Losses) | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||
28-Dec-13 | $ | 1,882 | $ | 67 | $ | 4 | $ | (14 | ) | $ | (602 | ) | $ | (94 | ) | $ | 1,243 | ||||||||||||
Other comprehensive income before reclassifications | (55 | ) | — | 33 | (49 | ) | (11 | ) | 25 | (57 | ) | ||||||||||||||||||
Amounts reclassified out of accumulated other comprehensive income | (63 | ) | — | (12 | ) | 1 | 10 | — | (64 | ) | |||||||||||||||||||
Tax effects | 41 | (2 | ) | (7 | ) | 6 | (1 | ) | (3 | ) | 34 | ||||||||||||||||||
Other comprehensive income (loss) | (77 | ) | (2 | ) | 14 | (42 | ) | (2 | ) | 22 | (87 | ) | |||||||||||||||||
29-Mar-14 | $ | 1,805 | $ | 65 | $ | 18 | $ | (56 | ) | $ | (604 | ) | $ | (72 | ) | $ | 1,156 | ||||||||||||
The amounts reclassified out of accumulated other comprehensive income into the consolidated condensed statements of income, with presentation location, for each period were as follows: | |||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||
Mar 29, | Mar 30, | ||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||
Comprehensive Income Components | Income Before Taxes Impact | Location | |||||||||||||||||||||||||||
(In Millions) | |||||||||||||||||||||||||||||
Unrealized holding gains (losses) on available-for-sale investments: | |||||||||||||||||||||||||||||
$ | 2 | $ | 3 | Interest and other, net | |||||||||||||||||||||||||
61 | 1 | Gains (losses) on equity investments, net | |||||||||||||||||||||||||||
63 | 4 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on derivatives: | |||||||||||||||||||||||||||||
Currency forwards | 2 | — | Cost of sales | ||||||||||||||||||||||||||
8 | 3 | Research and development | |||||||||||||||||||||||||||
2 | (1 | ) | Marketing, general and administrative | ||||||||||||||||||||||||||
12 | 2 | ||||||||||||||||||||||||||||
Amortization of pension and postretirement benefit components: | |||||||||||||||||||||||||||||
Prior service credits (costs) | (1 | ) | (1 | ) | |||||||||||||||||||||||||
Actuarial gains (losses) | (10 | ) | (25 | ) | |||||||||||||||||||||||||
(11 | ) | (26 | ) | ||||||||||||||||||||||||||
Total amounts reclassified out of accumulated other comprehensive income | $ | 64 | $ | (20 | ) | ||||||||||||||||||||||||
The amortization of pension and postretirement benefit components are included in the computation of net periodic benefit cost. For further information, see the "Retirement Benefit Plans" note in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 28, 2013. | |||||||||||||||||||||||||||||
We estimate that we will reclassify approximately $9 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months. |
Contingencies
Contingencies | 3 Months Ended |
Mar. 29, 2014 | |
Contingencies [Abstract] | ' |
Contingencies Disclosure [Text Block] | ' |
Note 19: Contingencies | |
Legal Proceedings | |
We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. Were unfavorable outcomes to occur, the possibility exists for a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. | |
A number of proceedings generally have challenged and continue to challenge certain of our competitive practices. The allegations in these proceedings vary and are described in more detail in the following paragraphs. In general, they contend that we improperly conditioned price rebates and other discounts on our microprocessors on exclusive or near-exclusive dealing by some of our customers; and they allege that our software compiler business unfairly preferred Intel® microprocessors over competing microprocessors and that, through the use of our compilers and other means, we have caused the dissemination of inaccurate and misleading benchmark results concerning our microprocessors. Based on the procedural posture of the various remaining competition matters, which we describe in subsequent paragraphs, our investment of resources to explain and defend our position has declined as compared to the period 2005-2011. Nonetheless, certain of the matters remain active, and these challenges could continue for a number of years, potentially requiring us to invest additional resources. We believe that we compete lawfully and that our marketing, business, intellectual property, and other challenged practices benefit our customers and our stockholders, and we will continue to conduct a vigorous defense in the remaining proceedings. | |
Government Competition Matters and Related Consumer Class Actions | |
In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. | |
In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged “conditional rebates and payments” that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged “payments to prevent sales of specific rival products.” The EC imposed a fine in the amount of €1.06 billion ($1.447 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to “immediately bring to an end the infringement referred to in” the EC decision. In the second quarter of 2009, we recorded the related charge within marketing, general and administrative. We strongly disagree with the EC's decision, and we appealed the decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place on July 3 through July 6, 2012. The court's decision is expected in mid-2014. | |
The EC decision exceeds 500 pages but contains no specific direction on whether or how we should modify our business practices. Instead, the decision states that we should “cease and desist” from further conduct that, in the EC's opinion, would violate applicable law. We have taken steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. Based on our current understanding and expectations, we do not believe that any such changes will be material to our financial position, results, or cash flows. | |
At least 82 separate class-action lawsuits have been filed in the U.S. District Courts for the Northern District of California, Southern District of California, District of Idaho, District of Nebraska, District of New Mexico, District of Maine, and District of Delaware, as well as in various California, Kansas, and Tennessee state courts. These actions generally repeat the allegations made in a now-settled lawsuit filed against us by AMD in June 2005 in the U.S. District Court for the District of Delaware (AMD litigation). Like the AMD litigation, these class-action lawsuits allege that we engaged in various actions in violation of the Sherman Act and other laws by, among other things: providing discounts and rebates to our manufacturer and distributor customers conditioned on exclusive or near-exclusive dealing that allegedly unfairly interfered with AMD's ability to sell its microprocessors; interfering with certain AMD product launches; and interfering with AMD's participation in certain industry standards-setting groups. The class actions allege various consumer injuries, including that consumers in various states have been injured by paying higher prices for computers containing our microprocessors. We dispute these class-action claims and intend to defend the lawsuits vigorously. | |
All of the federal class actions and the Kansas and Tennessee state court class actions have been transferred by the Multidistrict Litigation Panel to the U.S. District Court in Delaware for all pre-trial proceedings and discovery (MDL proceedings). The Delaware district court appointed a Special Master to address issues in the MDL proceedings, as assigned by the court. In January 2010, the plaintiffs in the Delaware action filed a motion for sanctions for our alleged failure to preserve evidence. This motion largely copies a motion previously filed by AMD in the AMD litigation, which has settled. The plaintiffs in the MDL proceedings also moved for certification of a class of members who purchased certain PCs containing products sold by us. In July 2010, the Special Master issued a Report and Recommendation (Report) denying the motion to certify a class. The MDL plaintiffs filed objections to the Special Master's Report, and a hearing on those objections was held in March 2011. In September 2012, the court ruled that an evidentiary hearing would be necessary to enable the court to rule on the objections to the Special Master's Report, to resolve the motion to certify the class, and to resolve a separate motion to exclude certain testimony and evidence from the MDL plaintiffs' expert. The hearing occurred in July 2013, and we are awaiting the court's decision on the class certification issues. | |
All California class actions have been consolidated in the Superior Court of California in Santa Clara County. The plaintiffs in the California actions have moved for class certification, which we are in the process of opposing. At our request, the court in the California actions has agreed to delay ruling on this motion until after the Delaware district court rules on the similar motion in the MDL proceedings. Given the procedural posture and the nature of these cases, including the fact that the Delaware district court has not determined whether the matters before it may proceed as a class action, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. | |
In re High Tech Employee Antitrust Litigation | |
Between May and July 2011, former employees of Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar filed antitrust class action lawsuits in the California Superior Courts alleging that these companies had entered into a conspiracy to suppress the compensation of their employees. The lawsuits were removed to the United States District Court for the Northern District of California, and in September 2011 the plaintiffs filed a consolidated amended complaint, captioned In re High Tech Employee Antitrust Litigation. The plaintiffs’ allegations reference the 2009 and 2010 investigation by the Department of Justice (DOJ) into employment practices in the technology industry, as well as the DOJ’s complaints and subsequent stipulated final judgments with the seven companies named as defendants in the lawsuits. The plaintiffs allege that the defendants entered into certain unlawful agreements not to cold call employees of particular other defendants and that there was an overarching conspiracy among the defendants. Plaintiffs assert one such agreement specific to Intel, namely that Intel and Google entered into an agreement starting in 2005, not to cold call each other's employees. Plaintiffs assert claims under Section 1 of the Sherman Antitrust Act and Section 4 of the Clayton Antitrust Act and seek a declaration that the defendants’ alleged actions violated the antitrust laws, damages trebled as provided for by law under the Sherman Act or Clayton Act, restitution and disgorgement, and attorneys’ fees and costs. | |
In October 2013, the court certified a class consisting of approximately 65,000 current or former employees of the seven defendants and set the matter for trial in late May 2014. The so-called “technical class” consists of a group of current and former technical, creative, and research and development employees at each of the defendants. In January 2014, Intel filed a motion for summary judgment, which the court denied in March 2014. | |
In April 2014, Intel, Adobe, Apple, and Google reached a tentative agreement with plaintiffs to settle this lawsuit, subject to completion and court approval of a written settlement agreement. We continue to dispute the plaintiffs’ claims, but have tentatively agreed to settle to avoid the uncertainties, expenses, and diversion of resources from continued litigation. Our operating expenses for the first quarter of 2014 reflect an accrual for this proceeding, and we believe reasonably possible losses in excess of the accrual amount are not material to our financial statements. | |
In re Intel Corporation Shareholder Derivative Litigation | |
In March 2014, the Police Retirement System of St. Louis filed a stockholder derivative action in the Superior Court of California in Santa Clara County Superior Court of California in Santa Clara County against the members of our Board of Directors, certain former Board members, and a current officer. The complaint alleges that the defendants breached their duties to the company by participating in, or allowing, alleged antitrust violations, as described in the In re High Tech Employee Antitrust Litigation. In March 2014, a second plaintiff, Barbara Templeton, filed a substantially similar derivative suit in the same court. In April 2014, the two actions were consolidated by the court into one case, captioned In re Intel Corporation Shareholder Derivative Litigation. We deny the allegations in these derivative suits and intend to defend the lawsuits vigorously. | |
Lehman Brothers Holdings Inc. and Lehman Brothers OTC Derivatives Inc. v. Intel | |
In May 2013, Lehman Brothers OTC Derivatives Inc. (LOTC) and Lehman Brothers Holdings Inc. (LBHI) filed an adversary complaint in the United States Bankruptcy Court in the Southern District of New York asserting claims against us arising from a 2008 contract between Intel and LOTC. Under the terms of the 2008 contract, we prepaid $1.0 billion to LOTC, in exchange for which LOTC was required to deliver to us on or before September 29, 2008, quantities of Intel common stock and cash determined by a formula set forth in the contract. LOTC's performance under the contract was secured by $1.0 billion of cash collateral. Under the terms of the contract, LOTC was obligated to deliver approximately 50 million shares of our common stock to us on September 29, 2008. LOTC failed to deliver any Intel common stock or cash, and we exercised our right of set-off against the $1.0 billion collateral. LOTC and LBHI acknowledge in their complaint that we were entitled to set off our losses against the collateral, but they assert that we withheld collateral in excess of our losses that should have been returned to LOTC. The complaint asserts a claim for breach of contract, a claim for “turnover” under section 542(a) of the Bankruptcy Code, and a claim for violation of the automatic stay under section 362(a)(3) of the Bankruptcy Code. The complaint does not expressly quantify the amount of damages claimed but does assert multiple theories of damages that impliedly seek up to $312 million of alleged excess collateral, plus interest based on LOTC's claimed cost of borrowing. In June 2013, we filed a motion to dismiss plaintiffs' bankruptcy claims and for a determination that the breach of contract claim is “non-core” under the Bankruptcy Code. The bankruptcy court granted our motion in its entirety in December 2013. In January 2014, based on the bankruptcy court’s ruling, we filed a motion in the United States District Court for the Southern District of New York requesting that the district court withdraw its reference to the bankruptcy court of plaintiffs’ adversary complaint. Given the procedural posture and the nature of this case, including that discovery is still in process, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter. We believe that we acted in a manner consistent with our contractual rights, and we intend to defend against any claim to the contrary. | |
McAfee, Inc. Shareholder Litigation | |
On August 19, 2010, we announced that we had agreed to acquire all of McAfee’s common stock for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08. | |
In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial, and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs filed a notice of appeal. Because the resolution of the appeal may materially impact the scope and nature of the proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously. | |
X2Y Attenuators, LLC v. Intel et al | |
In May 2011, X2Y Attenuators, LLC (X2Y) filed a patent infringement lawsuit in the U.S. District Court for the Western District of Pennsylvania and a complaint with the U.S. International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930 against us and two of our customers, Apple Inc. and Hewlett-Packard Company, alleging infringement of five patents. X2Y subsequently added a sixth patent to both actions. The district court action is stayed pending resolution of the ITC proceeding. X2Y alleges that at least Intel® Core™ and Intel® Xeon® processor families infringe the asserted patents. X2Y also requests that the ITC issue permanent exclusion and cease-and-desist orders to, among other things, prohibit us from importing these microprocessors and Apple and Hewlett-Packard Company products that incorporate these microprocessors into the United States. In the district court action, X2Y seeks unspecified damages, including enhanced damages for alleged willful infringement, and injunctive relief. On June 13, 2012, the Administrative Law Judge issued an initial determination granting X2Y’s motion to partially terminate the ITC investigation with respect to three of the asserted patents. The Administrative Law Judge held a hearing on the remaining three patents in August 2012 and issued an initial determination in December 2012. In the initial determination, the Administrative Law Judge found that Intel, Apple, and Hewlett-Packard Company have not violated Section 337 of the Tariff Act of 1930 because they have not infringed any of the asserted claims of the three patents, and ruled that the asserted claims of two of the patents were invalid. In December 2012, the parties filed petitions for review of the initial determination by the ITC. In February 2013, the ITC determined to review in part the initial determination. On review, the ITC determined to reverse or vacate certain findings, and to terminate the investigation with a finding of no violation. In April 2013, X2Y filed a Notice of Appeal with the United States Court of Appeals for the Federal Circuit. Given the procedural posture and nature of the cases, including the fact that resolution of the appeal of the ITC's decision may materially impact the scope and nature of the proceeding, the fact that monetary damages are not an available remedy in the ITC, and that discovery regarding X2Y’s claimed damages has not commenced in the stayed district court action, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute the claims and intend to defend the lawsuits vigorously. | |
Oregon Air Permit Matter | |
In April 2014, we entered into a Mutual Agreement and Order (MAO) with the Oregon Department of Environmental Quality (ODEQ) regarding a fluoride emissions issue that Intel discovered and reported to ODEQ in early 2012. The MAO alleges that we failed to comply with a number of application and reporting requirements over several years. The MAO sets a fine that is not material to our financial results and, among other things, requires us to obtain a proper air permit and test and report fluoride site emissions periodically. |
Operating_Segments_Information
Operating Segments Information | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Operating Segment Information [Abstract] | ' | ||||||||
Operating Segment Information [Text Block] | ' | ||||||||
Note 20: Operating Segments Information | |||||||||
Our operating segments in effect as of March 29, 2014 include: | |||||||||
• PC Client Group | • All other | ||||||||
• Data Center Group | • Non-Volatile Memory Solutions Group | ||||||||
• Internet of Things Group | • Netbook Group | ||||||||
• Mobile and Communications Group | • New Devices Group | ||||||||
• Software and services operating segments | |||||||||
• McAfee | |||||||||
• Software and Services Group | |||||||||
In the first three months of 2014, we formed the Internet of Things Group, which includes platforms and software-optimized for the Internet of Things market segment. Additionally, we changed our organizational structure to align with our critical objectives, which changed information that our Chief Operating Decision Maker (CODM) reviews for purposes of allocating resources and assessing performance. After the reorganization, we have nine operating segments: PC Client Group (PCCG), Data Center Group (DCG), Internet of Things Group (IOTG), Mobile and Communication Group (MCG), McAfee, Software and Services Group, Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group. All prior-period amounts have been adjusted retrospectively to reflect these operating segment changes, as well as other minor reorganizations. | |||||||||
The CODM is our Chief Executive Officer. The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss). | |||||||||
PCCG, DCG, and MCG are our reportable operating segments. IOTG and the aggregated “software and services operating segments” as shown in the preceding operating segment list, do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group operating segments do not meet the quantitative thresholds to qualify as reportable segments and their combined results are included within the “all other” category. | |||||||||
Revenue for our reportable and aggregated non-reportable operating segments is primarily related to the following product lines: | |||||||||
• | PC Client Group. Includes platforms designed for the notebook (including Ultrabook™ devices and 2 in 1 systems) and the desktop (including all-in-ones and high-end enthusiast PCs); wireless and wired connectivity products; as well as home gateway and set-top box components. | ||||||||
• | Data Center Group. Includes platforms designed for the server, workstation, networking, and storage computing market segments. | ||||||||
• | Internet of Things Group. Includes platforms designed for embedded applications for medical, automotive, industrial, retail, and other market segments; as well as software-optimized products for the embedded and mobile market segments. | ||||||||
• | Mobile and Communications Group. Includes platforms designed for the tablet and smartphone market segments; and mobile communications components such as baseband processors, radio frequency transceivers, Wi-Fi, Bluetooth® technology, global navigation satellite systems, and power management chips. | ||||||||
• | Software and services operating segments. Includes software products for endpoint security, network and content security, risk and compliance, and consumer and mobile security from our McAfee business, and software products and services that promote Intel architecture as the platform of choice for software development. | ||||||||
We have sales and marketing, manufacturing, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments, and the expenses are included in the operating results reported below. | |||||||||
The “all other” category includes revenue, expenses, and charges such as: | |||||||||
• | results of operations from our Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group; | ||||||||
• | amounts included within restructuring and asset impairment charges; | ||||||||
• | a portion of profit-dependent compensation and other expenses not allocated to the operating segments; | ||||||||
• | divested businesses for which discrete operating results are not regularly reviewed by our CODM; | ||||||||
• | results of operations of startup businesses that support our initiatives, including our foundry business; and | ||||||||
• | acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. | ||||||||
The CODM does not evaluate operating segments using discrete asset information. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole. | |||||||||
Net revenue and operating income (loss) for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Net revenue: | |||||||||
PC Client Group | $ | 7,941 | $ | 8,054 | |||||
Data Center Group | 3,087 | 2,777 | |||||||
Internet of Things Group | 482 | 365 | |||||||
Mobile and Communications Group | 156 | 404 | |||||||
Software and services operating segments | 553 | 520 | |||||||
All other | 545 | 460 | |||||||
Total net revenue | $ | 12,764 | $ | 12,580 | |||||
Operating income (loss): | |||||||||
PC Client Group | $ | 2,802 | $ | 2,488 | |||||
Data Center Group | 1,317 | 1,144 | |||||||
Internet of Things Group | 123 | 67 | |||||||
Mobile and Communications Group | (929 | ) | (703 | ) | |||||
Software and services operating segments | (7 | ) | (6 | ) | |||||
All other | (796 | ) | (471 | ) | |||||
Total operating income | $ | 2,510 | $ | 2,519 | |||||
Fair_Value_Tables
Fair Value (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Fair Value (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | 28-Dec-13 | ||||||||||||||||||||||||||||||||
Fair Value Measured and Recorded at Reporting Date Using | Fair Value Measured and Recorded at Reporting Date Using | ||||||||||||||||||||||||||||||||
(In Millions) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Corporate debt | $ | 154 | $ | 1,855 | $ | — | $ | 2,009 | $ | 154 | $ | 1,920 | $ | — | $ | 2,074 | |||||||||||||||||
Financial institution instruments | 173 | 1,763 | — | 1,936 | 887 | 1,190 | — | 2,077 | |||||||||||||||||||||||||
Government debt | — | 125 | — | 125 | — | 269 | — | 269 | |||||||||||||||||||||||||
Reverse repurchase agreements | — | 150 | — | 150 | — | 400 | — | 400 | |||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate debt | 269 | 1,250 | 19 | 1,538 | 274 | 1,374 | 19 | 1,667 | |||||||||||||||||||||||||
Financial institution instruments | 167 | 2,315 | — | 2,482 | 194 | 2,895 | — | 3,089 | |||||||||||||||||||||||||
Government debt | 368 | 846 | — | 1,214 | 183 | 1,033 | — | 1,216 | |||||||||||||||||||||||||
Trading assets: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 757 | 26 | 783 | — | 684 | 4 | 688 | |||||||||||||||||||||||||
Corporate debt | 2,450 | 635 | — | 3,085 | 2,161 | 628 | — | 2,789 | |||||||||||||||||||||||||
Financial institution instruments | 1,194 | 450 | — | 1,644 | 1,188 | 418 | — | 1,606 | |||||||||||||||||||||||||
Government debt | 1,638 | 1,885 | — | 3,523 | 1,625 | 1,733 | — | 3,358 | |||||||||||||||||||||||||
Other current assets: | |||||||||||||||||||||||||||||||||
Derivative assets | 12 | 230 | — | 242 | 48 | 309 | — | 357 | |||||||||||||||||||||||||
Loans receivable | — | 257 | — | 257 | — | 103 | — | 103 | |||||||||||||||||||||||||
Marketable equity securities | 6,085 | — | — | 6,085 | 6,221 | — | — | 6,221 | |||||||||||||||||||||||||
Other long-term investments: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | — | 9 | 9 | — | — | 9 | 9 | |||||||||||||||||||||||||
Corporate debt | 463 | 458 | 27 | 948 | 228 | 270 | 27 | 525 | |||||||||||||||||||||||||
Financial institution instruments | 131 | 330 | — | 461 | 90 | 402 | — | 492 | |||||||||||||||||||||||||
Government debt | 168 | 179 | — | 347 | 259 | 188 | — | 447 | |||||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 5 | 30 | 35 | — | 7 | 29 | 36 | |||||||||||||||||||||||||
Loans receivable | — | 556 | — | 556 | — | 702 | — | 702 | |||||||||||||||||||||||||
Total assets measured and recorded at fair value | $ | 13,272 | $ | 14,046 | $ | 111 | $ | 27,429 | $ | 13,512 | $ | 14,525 | $ | 88 | $ | 28,125 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||
Other accrued liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | $ | 7 | $ | 355 | $ | — | $ | 362 | $ | — | $ | 372 | $ | — | $ | 372 | |||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 47 | — | 47 | — | 50 | — | 50 | |||||||||||||||||||||||||
Total liabilities measured and recorded at fair value | $ | 7 | $ | 402 | $ | — | $ | 409 | $ | — | $ | 422 | $ | — | $ | 422 | |||||||||||||||||
Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 569 | $ | — | $ | 576 | $ | — | $ | 576 | |||||||||||||||||||||||
Loans receivable | $ | 259 | $ | — | $ | 250 | $ | 9 | $ | 259 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,285 | $ | — | $ | — | $ | 2,120 | $ | 2,120 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 432 | $ | — | $ | 432 | $ | — | $ | 432 | |||||||||||||||||||||||
Short-term debt | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||
Long-term debt | $ | 13,172 | $ | 11,224 | $ | 2,714 | $ | — | $ | 13,938 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 389 | $ | — | $ | 397 | $ | — | $ | 397 | |||||||||||||||||||||||
28-Dec-13 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 416 | $ | — | $ | 481 | $ | — | $ | 481 | |||||||||||||||||||||||
Loans receivable | $ | 267 | $ | — | $ | 250 | $ | 17 | $ | 267 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,270 | $ | — | $ | — | $ | 2,105 | $ | 2,105 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 400 | $ | — | $ | 400 | $ | — | $ | 400 | |||||||||||||||||||||||
Short-term debt | $ | 24 | $ | — | $ | 24 | $ | — | $ | 24 | |||||||||||||||||||||||
Long-term debt | $ | 13,165 | $ | 10,937 | $ | 2,601 | $ | — | $ | 13,538 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 587 | $ | — | $ | 597 | $ | — | $ | 597 | |||||||||||||||||||||||
Cash_and_Investments_Tables
Cash and Investments (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Cash and Investments [Abstract] | ' | ||||||||
Schedule of Total Cash and Investments [Table Text Block] | ' | ||||||||
Cash and investments at the end of each period were as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Available-for-sale investments | $ | 17,154 | $ | 18,086 | |||||
Cash | 557 | 854 | |||||||
Equity method investments | 1,107 | 1,038 | |||||||
Loans receivable | 1,072 | 1,072 | |||||||
Non-marketable cost method investments | 1,285 | 1,270 | |||||||
Reverse repurchase agreements | 582 | 800 | |||||||
Trading assets | 9,035 | 8,441 | |||||||
Total cash and investments | $ | 30,792 | $ | 31,561 | |||||
Cash_and_Investments_Available
Cash and Investments, Available-for-Sale Investments (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Available-for-Sale Investments (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
Available-for-sale investments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | 28-Dec-13 | ||||||||||||||||||||||||||||||||
(In Millions) | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||
Asset-backed securities | $ | 10 | $ | 1 | $ | (2 | ) | $ | 9 | $ | 11 | $ | — | $ | (2 | ) | $ | 9 | |||||||||||||||
Corporate debt | 4,482 | 15 | (2 | ) | 4,495 | 4,254 | 15 | (3 | ) | 4,266 | |||||||||||||||||||||||
Financial institution instruments | 4,874 | 6 | (1 | ) | 4,879 | 5,654 | 5 | (1 | ) | 5,658 | |||||||||||||||||||||||
Government debt | 1,686 | — | — | 1,686 | 1,932 | 1 | (1 | ) | 1,932 | ||||||||||||||||||||||||
Marketable equity securities | 3,321 | 2,764 | — | 6,085 | 3,340 | 2,881 | — | 6,221 | |||||||||||||||||||||||||
Total available-for-sale investments | $ | 14,373 | $ | 2,786 | $ | (5 | ) | $ | 17,154 | $ | 15,191 | $ | 2,902 | $ | (7 | ) | $ | 18,086 | |||||||||||||||
Available-for-sale Securities [Member] | ' | ||||||||||||||||||||||||||||||||
Available-for-Sale Investments (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||||||
Investments Classified by Contractual Maturity Date [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of March 29, 2014, were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 8,703 | $ | 8,722 | |||||||||||||||||||||||||||||
Due in 1–2 years | 1,007 | 1,006 | |||||||||||||||||||||||||||||||
Due in 2–5 years | 750 | 751 | |||||||||||||||||||||||||||||||
Instruments not due at a single maturity date | 592 | 590 | |||||||||||||||||||||||||||||||
Total | $ | 11,052 | $ | 11,069 | |||||||||||||||||||||||||||||
Inventories_Tables
Inventories (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Inventories (Tables) [Abstract] | ' | ||||||||
Schedule of Inventory, Current [Table Text Block] | ' | ||||||||
Inventories at the end of each period were as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Raw materials | $ | 463 | $ | 458 | |||||
Work in process | 1,803 | 1,998 | |||||||
Finished goods | 1,497 | 1,716 | |||||||
Total inventories | $ | 3,763 | $ | 4,172 | |||||
Derivative_Financial_Instrumen1
Derivative Financial Instruments (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||||||
Derivative Financial Instruments (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||||||
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Dec 28, | Mar 30, | ||||||||||||||||||||||||||||||
2014 | 2013 | 2013 | |||||||||||||||||||||||||||||||
Currency forwards | $ | 11,729 | $ | 13,404 | $ | 13,141 | |||||||||||||||||||||||||||
Currency interest rate swaps | 4,795 | 4,377 | 3,464 | ||||||||||||||||||||||||||||||
Embedded debt derivatives | 3,600 | 3,600 | 3,600 | ||||||||||||||||||||||||||||||
Interest rate swaps | 1,311 | 1,377 | 1,041 | ||||||||||||||||||||||||||||||
Total return swaps | 989 | 914 | 859 | ||||||||||||||||||||||||||||||
Other | 60 | 67 | 82 | ||||||||||||||||||||||||||||||
Total | $ | 22,484 | $ | 23,739 | $ | 22,187 | |||||||||||||||||||||||||||
The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Dec 28, | Mar 30, | ||||||||||||||||||||||||||||||
2014 | 2013 | 2013 | |||||||||||||||||||||||||||||||
British pound sterling | $ | 487 | $ | 549 | $ | 422 | |||||||||||||||||||||||||||
Chinese yuan | 1,291 | 1,116 | 572 | ||||||||||||||||||||||||||||||
Euro | 6,199 | 6,874 | 6,800 | ||||||||||||||||||||||||||||||
Israeli shekel | 1,878 | 2,244 | 1,974 | ||||||||||||||||||||||||||||||
Japanese yen | 3,542 | 4,116 | 3,854 | ||||||||||||||||||||||||||||||
Malaysian ringgit | 524 | 506 | 520 | ||||||||||||||||||||||||||||||
Swiss franc | 1,256 | 1,189 | 1,312 | ||||||||||||||||||||||||||||||
Other | 1,347 | 1,187 | 1,151 | ||||||||||||||||||||||||||||||
Total | $ | 16,524 | $ | 17,781 | $ | 16,605 | |||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The fair value of our derivative instruments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
March 29, 2014 | December 28, 2013 | ||||||||||||||||||||||||||||||||
(In Millions) | Other | Other | Other | Other | Other | Other | Other | Other | |||||||||||||||||||||||||
Current | Long-Term | Accrued | Long-Term | Current | Long-Term | Accrued | Long-Term | ||||||||||||||||||||||||||
Assets | Assets | Liabilities | Liabilities | Assets | Assets | Liabilities | Liabilities | ||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 86 | $ | — | $ | 53 | $ | 1 | $ | 114 | $ | 1 | $ | 118 | $ | 2 | |||||||||||||||||
Other | — | — | 3 | — | — | — | — | — | |||||||||||||||||||||||||
Total derivatives designated as hedging instruments | $ | 86 | $ | — | $ | 56 | $ | 1 | $ | 114 | $ | 1 | $ | 118 | $ | 2 | |||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 36 | $ | — | $ | 80 | $ | — | $ | 66 | $ | — | $ | 63 | $ | — | |||||||||||||||||
Currency interest rate swaps | 104 | 5 | 197 | 32 | 124 | 6 | 163 | 29 | |||||||||||||||||||||||||
Embedded debt derivatives | — | — | — | 14 | — | — | — | 19 | |||||||||||||||||||||||||
Interest rate swaps | 4 | — | 22 | — | 5 | — | 28 | — | |||||||||||||||||||||||||
Total return swaps | 12 | — | 7 | — | 48 | — | — | — | |||||||||||||||||||||||||
Other | — | 30 | — | — | — | 29 | — | — | |||||||||||||||||||||||||
Total derivatives not designated as hedging instruments | $ | 156 | $ | 35 | $ | 306 | $ | 46 | $ | 243 | $ | 35 | $ | 254 | $ | 48 | |||||||||||||||||
Total derivatives | $ | 242 | $ | 35 | $ | 362 | $ | 47 | $ | 357 | $ | 36 | $ | 372 | $ | 50 | |||||||||||||||||
Offsetting Assets And Liabilities [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties and cash and non-cash collateral posted under such agreements at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 221 | $ | — | $ | 221 | $ | (158 | ) | $ | (9 | ) | $ | 54 | |||||||||||||||||||
Reverse repurchase agreements | 582 | — | 582 | — | (582 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 803 | $ | — | $ | 803 | $ | (158 | ) | $ | (591 | ) | $ | 54 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 391 | $ | — | $ | 391 | $ | (158 | ) | $ | (181 | ) | $ | 52 | |||||||||||||||||||
Total liabilities | $ | 391 | $ | — | $ | 391 | $ | (158 | ) | $ | (181 | ) | $ | 52 | |||||||||||||||||||
28-Dec-13 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 325 | $ | — | $ | 325 | $ | (158 | ) | $ | (3 | ) | $ | 164 | |||||||||||||||||||
Reverse repurchase agreements | 800 | — | 800 | — | (800 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,125 | $ | — | $ | 1,125 | $ | (158 | ) | $ | (803 | ) | $ | 164 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 401 | $ | — | $ | 401 | $ | (158 | ) | $ | (32 | ) | $ | 211 | |||||||||||||||||||
Total liabilities | $ | 401 | $ | — | $ | 401 | $ | (158 | ) | $ | (32 | ) | $ | 211 | |||||||||||||||||||
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Currency forwards | $ | 35 | $ | (236 | ) | ||||||||||||||||||||||||||||
Other | (2 | ) | 1 | ||||||||||||||||||||||||||||||
Total | $ | 33 | $ | (235 | ) | ||||||||||||||||||||||||||||
Not Designated as Hedging Instrument [Member] | ' | ||||||||||||||||||||||||||||||||
Derivative Financial Instruments (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] | ' | ||||||||||||||||||||||||||||||||
The effects of derivative instruments not designated as hedging instruments on the consolidated condensed statements of income for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Location of Gains (Losses) | Mar 29, | Mar 30, | ||||||||||||||||||||||||||||||
Recognized in Income on Derivatives | 2014 | 2013 | |||||||||||||||||||||||||||||||
Currency forwards | Interest and other, net | $ | (15 | ) | $ | 56 | |||||||||||||||||||||||||||
Currency interest rate swaps | Interest and other, net | (54 | ) | 100 | |||||||||||||||||||||||||||||
Total return swaps | Various | 13 | 48 | ||||||||||||||||||||||||||||||
Other | Gains (losses) on equity investments, net | 1 | 2 | ||||||||||||||||||||||||||||||
Total | $ | (55 | ) | $ | 206 | ||||||||||||||||||||||||||||
Goodwill_Tables
Goodwill (Tables) | 3 Months Ended | ||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||
Goodwill (Tables) [Abstract] | ' | ||||||||||||||||||||
Schedule of Goodwill [Table Text Block] | ' | ||||||||||||||||||||
Goodwill activity for the first three months of 2014 was as follows: | |||||||||||||||||||||
(In Millions) | Dec 28, | Additions Due to Acquisitions | Transfers | Effect of Exchange Rate Fluctuations and Other | Mar 29, | ||||||||||||||||
2013 | 2014 | ||||||||||||||||||||
PC Client Group | $ | 3,058 | $ | — | $ | — | $ | — | $ | 3,058 | |||||||||||
Data Center Group | 1,831 | 8 | 138 | — | 1,977 | ||||||||||||||||
Internet of Things Group | — | — | 428 | — | 428 | ||||||||||||||||
Mobile and Communications Group | — | — | 631 | — | 631 | ||||||||||||||||
Other Intel architecture operating segments | 1,075 | — | (1,075 | ) | — | — | |||||||||||||||
Software and services operating segments | 4,549 | — | (140 | ) | 23 | 4,432 | |||||||||||||||
All other | — | 91 | 18 | (18 | ) | 91 | |||||||||||||||
Total | $ | 10,513 | $ | 99 | $ | — | $ | 5 | $ | 10,617 | |||||||||||
Identified_Intangible_Assets_T
Identified Intangible Assets (Tables) | 3 Months Ended | ||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||
Identified Intangible Assets (Tables) [Abstract] | ' | ||||||||||||||||||||
Schedule Of Intangible Assets By Major Class [Table Text Block] | ' | ||||||||||||||||||||
Identified intangible assets at the end of each period were as follows: | |||||||||||||||||||||
29-Mar-14 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,932 | $ | (1,841 | ) | $ | 1,091 | ||||||||||||||
Acquisition-related customer relationships | 1,766 | (901 | ) | 865 | |||||||||||||||||
Acquisition-related trade names | 65 | (47 | ) | 18 | |||||||||||||||||
Licensed technology and patents | 3,088 | (1,017 | ) | 2,071 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,851 | (3,806 | ) | 4,045 | |||||||||||||||||
Acquisition-related trade names | 821 | — | 821 | ||||||||||||||||||
Other intangible assets | 97 | — | 97 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 918 | — | 918 | ||||||||||||||||||
Total identified intangible assets | $ | 8,769 | $ | (3,806 | ) | $ | 4,963 | ||||||||||||||
December 28, 2013 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,922 | $ | (1,691 | ) | $ | 1,231 | ||||||||||||||
Acquisition-related customer relationships | 1,760 | (828 | ) | 932 | |||||||||||||||||
Acquisition-related trade names | 65 | (44 | ) | 21 | |||||||||||||||||
Licensed technology and patents | 3,093 | (974 | ) | 2,119 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,840 | (3,537 | ) | 4,303 | |||||||||||||||||
Acquisition-related trade names | 818 | — | 818 | ||||||||||||||||||
Other intangible assets | 29 | — | 29 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 847 | — | 847 | ||||||||||||||||||
Total identified intangible assets | $ | 8,687 | $ | (3,537 | ) | $ | 5,150 | ||||||||||||||
Identified Intangible Assets, Amortization Expenses [Table Text Block] | ' | ||||||||||||||||||||
Amortization expenses for each period were as follows: | |||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
Acquisition-related developed technology | $ | 146 | $ | 140 | |||||||||||||||||
Acquisition-related customer relationships | 70 | 70 | |||||||||||||||||||
Acquisition-related trade names | 3 | 3 | |||||||||||||||||||
Licensed technology and patents | 68 | 66 | |||||||||||||||||||
Other intangible assets | — | 103 | |||||||||||||||||||
Total amortization expenses | $ | 287 | $ | 382 | |||||||||||||||||
Schedule of Expected Amortization Expense [Table Text Block] | ' | ||||||||||||||||||||
Based on identified intangible assets that are subject to amortization as of March 29, 2014, we expect future amortization expenses for each period to be as follows: | |||||||||||||||||||||
(In Millions) | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | ||||||||||||||||
Acquisition-related developed technology | $ | 434 | $ | 303 | $ | 211 | $ | 63 | $ | 41 | |||||||||||
Acquisition-related customer relationships | 200 | 252 | 234 | 142 | 29 | ||||||||||||||||
Acquisition-related trade names | 7 | 8 | 3 | — | — | ||||||||||||||||
Licensed technology and patents | 203 | 254 | 239 | 200 | 159 | ||||||||||||||||
Total future amortization expenses | $ | 844 | $ | 817 | $ | 687 | $ | 405 | $ | 229 | |||||||||||
Other_LongTerm_Assets_Tables
Other Long-Term Assets (Tables) (Other Long-Term Assets [Member]) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Other Long-Term Assets [Member] | ' | ||||||||
Other Long-Term Assets (Tables) [Abstract] | ' | ||||||||
Schedule of Other Assets and Other Liabilities [Table Text Block] | ' | ||||||||
Other long-term assets at the end of each period were as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Equity method investments | $ | 1,107 | $ | 1,038 | |||||
Non-marketable cost method investments | 1,285 | 1,270 | |||||||
Non-current deferred tax assets | 449 | 434 | |||||||
Loans receivable | 806 | 952 | |||||||
Prepayments for property, plant and equipment | 457 | 521 | |||||||
Other | 1,342 | 1,274 | |||||||
Total other long-term assets | $ | 5,446 | $ | 5,489 | |||||
Restructuring_and_Asset_Impair1
Restructuring and Asset Impairment Charges (Tables) | 3 Months Ended | ||||||||||||
Mar. 29, 2014 | |||||||||||||
RestructuringAndAssetImpairmentChargesTables [Abstract] | ' | ||||||||||||
Restructuring And Asset Impairment Charges [Table Text Block] | ' | ||||||||||||
Restructuring and asset impairment charges for each period were as follows: | |||||||||||||
Three Months Ended | |||||||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||||||
2014 | 2013 | ||||||||||||
Employee severance and benefit arrangements | $ | 137 | $ | — | |||||||||
Asset impairments | — | — | |||||||||||
Total restructuring and asset impairment charges | $ | 137 | $ | — | |||||||||
Restructuring And Asset Impairment Activity [Table Text Block] | ' | ||||||||||||
The restructuring and asset impairment activity for first three months of 2014 was as follows: | |||||||||||||
(In Millions) | Employee Severance and Benefits | Asset Impairments | Total | ||||||||||
Accrued restructuring balance as of December 28, 2013 | $ | 183 | $ | — | $ | 183 | |||||||
Additional accruals | 139 | — | 139 | ||||||||||
Adjustments | (2 | ) | — | (2 | ) | ||||||||
Cash payments | (57 | ) | — | (57 | ) | ||||||||
Accrued restructuring balance as of March 29, 2014 | $ | 263 | $ | — | $ | 263 | |||||||
Deferred_Income_Tables
Deferred Income (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Deferred Income (Tables) [Abstract] | ' | ||||||||
Deferred Income By Arrangement Disclosure [Table Text Block] | ' | ||||||||
Deferred income at the end of each period was as follows: | |||||||||
(In Millions) | Mar 29, | Dec 28, | |||||||
2014 | 2013 | ||||||||
Deferred income on shipments of components to distributors | $ | 928 | $ | 852 | |||||
Deferred income from software and services operating segments | 1,243 | 1,244 | |||||||
Current deferred income | 2,171 | 2,096 | |||||||
Non-current deferred income from software and services operating segments | 482 | 506 | |||||||
Total deferred income | $ | 2,653 | $ | 2,602 | |||||
Employee_Equity_Incentive_Plan1
Employee Equity Incentive Plans (Tables) | 3 Months Ended | |||||||
Mar. 29, 2014 | ||||||||
Employee Equity Incentive Plans (Tables) [Abstract] | ' | |||||||
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] | ' | |||||||
Information with respect to outstanding restricted stock unit (RSU) activity in the first three months of 2014 was as follows: | ||||||||
Number of | Weighted Average | |||||||
RSUs | Grant-Date | |||||||
(In Millions) | Fair Value | |||||||
December 28, 2013 | 113.3 | $ | 22.47 | |||||
Granted | 3.6 | $ | 26.28 | |||||
Vested | (3.1 | ) | $ | 23.06 | ||||
Forfeited | (2.7 | ) | $ | 22.44 | ||||
March 29, 2014 | 111.1 | $ | 22.58 | |||||
Schedule of Stock Options Roll Forward [Table Text Block] | ' | |||||||
Information with respect to outstanding stock option activity in the first three months of 2014 was as follows: | ||||||||
Number of | Weighted Average | |||||||
Options | Exercise Price | |||||||
(In Millions) | ||||||||
December 28, 2013 | 153 | $ | 21.1 | |||||
Granted | 0.5 | $ | 25.08 | |||||
Exercised | (13.9 | ) | $ | 19.26 | ||||
Cancelled and forfeited | (1.3 | ) | $ | 23.48 | ||||
Expired | (0.3 | ) | $ | 31.34 | ||||
March 29, 2014 | 138 | $ | 21.26 | |||||
Options exercisable as of: | ||||||||
December 28, 2013 | 111.5 | $ | 20.25 | |||||
March 29, 2014 | 102.3 | $ | 20.37 | |||||
Gains_Losses_on_Equity_Investm1
Gains (Losses) on Equity Investments, Net (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Gains (Losses) on Equity Investments, Net (Tables) [Abstract] | ' | ||||||||
Schedule Of Gains (Losses) On Equity Investments, Net [Table Text Block] | ' | ||||||||
The components of gains (losses) on equity investments, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Share of equity method investee losses, net | $ | (11 | ) | $ | (23 | ) | |||
Impairment charges | (38 | ) | (17 | ) | |||||
Gains on sales, net | 71 | 4 | |||||||
Other, net | 26 | 10 | |||||||
Total gains (losses) on equity investments, net | $ | 48 | $ | (26 | ) | ||||
Interest_and_Other_Net_Tables
Interest and Other, Net (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Interest and Other, Net (Tables) [Abstract] | ' | ||||||||
Interest And Other, Net [Table Text Block] | ' | ||||||||
The components of interest and other, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Interest income | $ | 35 | $ | 23 | |||||
Interest expense | (37 | ) | (73 | ) | |||||
Other, net | 114 | — | |||||||
Total interest and other, net | $ | 112 | $ | (50 | ) | ||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | ' | ||||||||
We computed our basic and diluted earnings per common share for each period as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions, Except Per Share Amounts) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Net income available to common stockholders | $ | 1,930 | $ | 2,045 | |||||
Weighted average common shares outstanding—basic | 4,974 | 4,948 | |||||||
Dilutive effect of employee equity incentive plans | 76 | 78 | |||||||
Dilutive effect of convertible debt | 67 | 54 | |||||||
Weighted average common shares outstanding—diluted | 5,117 | 5,080 | |||||||
Basic earnings per common share | $ | 0.39 | $ | 0.41 | |||||
Diluted earnings per common share | $ | 0.38 | $ | 0.4 | |||||
Other_Comprehensive_Income_Los1
Other Comprehensive Income (Loss) (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||
Mar. 29, 2014 | |||||||||||||||||||||||||||||
Comprehensive Income (Tables) [Abstract] | ' | ||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | ' | ||||||||||||||||||||||||||||
The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2014 were as follows: | |||||||||||||||||||||||||||||
(In Millions) | Unrealized Holding Gains (Losses) on Available-for-Sale Investments | Deferred Tax Asset Valuation Allowance | Unrealized Holding Gains (Losses) on Derivatives | Prior Service Credits (Costs) | Actuarial Gains (Losses) | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||
28-Dec-13 | $ | 1,882 | $ | 67 | $ | 4 | $ | (14 | ) | $ | (602 | ) | $ | (94 | ) | $ | 1,243 | ||||||||||||
Other comprehensive income before reclassifications | (55 | ) | — | 33 | (49 | ) | (11 | ) | 25 | (57 | ) | ||||||||||||||||||
Amounts reclassified out of accumulated other comprehensive income | (63 | ) | — | (12 | ) | 1 | 10 | — | (64 | ) | |||||||||||||||||||
Tax effects | 41 | (2 | ) | (7 | ) | 6 | (1 | ) | (3 | ) | 34 | ||||||||||||||||||
Other comprehensive income (loss) | (77 | ) | (2 | ) | 14 | (42 | ) | (2 | ) | 22 | (87 | ) | |||||||||||||||||
29-Mar-14 | $ | 1,805 | $ | 65 | $ | 18 | $ | (56 | ) | $ | (604 | ) | $ | (72 | ) | $ | 1,156 | ||||||||||||
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] | ' | ||||||||||||||||||||||||||||
The amounts reclassified out of accumulated other comprehensive income into the consolidated condensed statements of income, with presentation location, for each period were as follows: | |||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||
Mar 29, | Mar 30, | ||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||
Comprehensive Income Components | Income Before Taxes Impact | Location | |||||||||||||||||||||||||||
(In Millions) | |||||||||||||||||||||||||||||
Unrealized holding gains (losses) on available-for-sale investments: | |||||||||||||||||||||||||||||
$ | 2 | $ | 3 | Interest and other, net | |||||||||||||||||||||||||
61 | 1 | Gains (losses) on equity investments, net | |||||||||||||||||||||||||||
63 | 4 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on derivatives: | |||||||||||||||||||||||||||||
Currency forwards | 2 | — | Cost of sales | ||||||||||||||||||||||||||
8 | 3 | Research and development | |||||||||||||||||||||||||||
2 | (1 | ) | Marketing, general and administrative | ||||||||||||||||||||||||||
12 | 2 | ||||||||||||||||||||||||||||
Amortization of pension and postretirement benefit components: | |||||||||||||||||||||||||||||
Prior service credits (costs) | (1 | ) | (1 | ) | |||||||||||||||||||||||||
Actuarial gains (losses) | (10 | ) | (25 | ) | |||||||||||||||||||||||||
(11 | ) | (26 | ) | ||||||||||||||||||||||||||
Total amounts reclassified out of accumulated other comprehensive income | $ | 64 | $ | (20 | ) | ||||||||||||||||||||||||
Operating_Segments_Information1
Operating Segments Information (Tables) | 3 Months Ended | ||||||||
Mar. 29, 2014 | |||||||||
Operating Segment Information (Tables) [Abstract] | ' | ||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | ' | ||||||||
Net revenue and operating income (loss) for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 29, | Mar 30, | |||||||
2014 | 2013 | ||||||||
Net revenue: | |||||||||
PC Client Group | $ | 7,941 | $ | 8,054 | |||||
Data Center Group | 3,087 | 2,777 | |||||||
Internet of Things Group | 482 | 365 | |||||||
Mobile and Communications Group | 156 | 404 | |||||||
Software and services operating segments | 553 | 520 | |||||||
All other | 545 | 460 | |||||||
Total net revenue | $ | 12,764 | $ | 12,580 | |||||
Operating income (loss): | |||||||||
PC Client Group | $ | 2,802 | $ | 2,488 | |||||
Data Center Group | 1,317 | 1,144 | |||||||
Internet of Things Group | 123 | 67 | |||||||
Mobile and Communications Group | (929 | ) | (703 | ) | |||||
Software and services operating segments | (7 | ) | (6 | ) | |||||
All other | (796 | ) | (471 | ) | |||||
Total operating income | $ | 2,510 | $ | 2,519 | |||||
Fair_Value_Detail
Fair Value (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Mar. 30, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Measurements, Nonrecurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Carrying Amount [Member] | Carrying Amount [Member] | Carrying Amount [Member] | Carrying Amount [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Marketable Equity Securities [Member] | Marketable Equity Securities [Member] | Debt Securities and Financial Instituition Instruments [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Marketable Equity Securities [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Marketable Equity Securities [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Fair Value [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Corporate Debt [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Financial Institution Instruments [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Government Debt [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Asset-Backed Securities [Member] | Marketable Equity Securities [Member] | Marketable Equity Securities [Member] | ||||||||
NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Cash Equivalents [Member] | Cash Equivalents [Member] | Short-Term Investments [Member] | Short-Term Investments [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Other Long-Term Investments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | ||||||||||||||||||||||||||||||||||||||
NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | NVIDIA cross-license agreement [Member] | NVIDIA cross-license agreement [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Investments, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2,009 | $2,074 | $1,538 | $1,667 | $948 | $525 | ' | ' | $1,936 | $2,077 | $2,482 | $3,089 | $461 | $492 | ' | ' | $125 | $269 | $1,214 | $1,216 | $347 | $447 | ' | ' | $9 | $9 | $6,085 | $6,221 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $154 | $154 | $269 | $274 | $463 | $228 | ' | ' | $173 | $887 | $167 | $194 | $131 | $90 | ' | ' | $0 | $0 | $368 | $183 | $168 | $259 | ' | ' | $0 | $0 | $6,085 | $6,221 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,855 | $1,920 | $1,250 | $1,374 | $458 | $270 | ' | ' | $1,763 | $1,190 | $2,315 | $2,895 | $330 | $402 | ' | ' | $125 | $269 | $846 | $1,033 | $179 | $188 | ' | ' | $0 | $0 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | $19 | $19 | $27 | $27 | ' | ' | $0 | $0 | $0 | $0 | $0 | $0 | ' | ' | $0 | $0 | $0 | $0 | $0 | $0 | ' | ' | $9 | $9 | $0 | $0 |
Reverse repurchase agreements, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | 150 | 400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150 | 400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Trading investments, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,085 | 2,789 | ' | ' | ' | ' | ' | ' | 1,644 | 1,606 | ' | ' | ' | ' | ' | ' | 3,523 | 3,358 | ' | ' | ' | ' | ' | ' | 783 | 688 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,450 | 2,161 | ' | ' | ' | ' | ' | ' | 1,194 | 1,188 | ' | ' | ' | ' | ' | ' | 1,638 | 1,625 | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 635 | 628 | ' | ' | ' | ' | ' | ' | 450 | 418 | ' | ' | ' | ' | ' | ' | 1,885 | 1,733 | ' | ' | ' | ' | ' | ' | 757 | 684 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | 26 | 4 | ' | ' | ' | ' |
Derivative assets, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | 242 | 357 | 35 | 36 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12 | 48 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 230 | 309 | 5 | 7 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 30 | 29 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loans receivable, Fair Value Disclosure | 813 | 805 | ' | ' | ' | ' | ' | ' | 257 | 103 | 556 | 702 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 257 | 103 | 556 | 702 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Assets, Fair Value Disclosure, Recurring | ' | ' | 27,429 | 28,125 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 13,272 | 13,512 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,046 | 14,525 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 111 | 88 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Derivative liabilities, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 362 | 372 | 47 | 50 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 355 | 372 | 47 | 50 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Liabilities, Fair Value Disclosure | ' | ' | 409 | 422 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 402 | 422 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 230 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair Value, Non-Marketable Equity Investments, Gains (Losses) | ' | ' | ' | ' | -38 | -14 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Grants Receivable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 569 | 416 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Grants Receivable, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 576 | 481 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 576 | 481 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loans receivable | 1,072 | 1,072 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 259 | 267 | ' | ' | 259 | 267 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 250 | 250 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9 | 17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-marketable cost method investments | 1,285 | 1,270 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,285 | 1,270 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-marketable cost method investments, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,120 | 2,105 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,120 | 2,105 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Reverse repurchase agreements | 582 | 800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 432 | 400 | ' | ' | 432 | 400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 432 | 400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Short-term debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Short-term debt, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 13,172 | 13,165 | ' | ' | 13,938 | 13,538 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 11,224 | 10,937 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,714 | 2,601 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Notes payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 389 | 587 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Notes payable, Fair Value Disclosure | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $397 | $597 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $397 | $597 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash_and_Investments_Detail
Cash and Investments (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Cash and Investments [Abstract] | ' | ' |
Available-for-sale investments | $17,154 | $18,086 |
Cash | 557 | 854 |
Equity method investments | 1,107 | 1,038 |
Loans receivable | 1,072 | 1,072 |
Non-marketable cost method investments | 1,285 | 1,270 |
Reverse repurchase agreements | 582 | 800 |
Trading assets | 9,035 | 8,441 |
Total cash and investments | $30,792 | $31,561 |
Cash_and_Investments_Available1
Cash and Investments, Available-for-Sale Investments (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 | Dec. 28, 2013 |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Gross Unrealized Gains | $2,786 | ' | $2,902 |
Gross Unrealized Losses | -5 | ' | -7 |
Fair Value | 11,069 | ' | ' |
Adjusted Cost, Total | 14,373 | ' | 15,191 |
Fair Value, Total | 17,154 | ' | 18,086 |
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds | 174 | 300 | ' |
Due in 1 year or less, Cost | 8,703 | ' | ' |
Due in 1-2 years, Cost | 1,007 | ' | ' |
Due in 2-5 years, Cost | 750 | ' | ' |
Instruments not due at a single maturity date, Cost | 592 | ' | ' |
Cost, Total | 11,052 | ' | ' |
Due in 1 year or less, Fair Value | 8,722 | ' | ' |
Due in 1-2 years, Fair Value | 1,006 | ' | ' |
Due in 2-5 years, Fair Value | 751 | ' | ' |
Instruments not due at a single maturity date, Fair Value | 590 | ' | ' |
Available-for-sale Securities, Gross Realized Gains | 67 | ' | ' |
Asset-Backed Securities [Member] | ' | ' | ' |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Adjusted Cost | 10 | ' | 11 |
Gross Unrealized Gains | 1 | ' | 0 |
Gross Unrealized Losses | -2 | ' | -2 |
Fair Value | 9 | ' | 9 |
Corporate Debt [Member] | ' | ' | ' |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Adjusted Cost | 4,482 | ' | 4,254 |
Gross Unrealized Gains | 15 | ' | 15 |
Gross Unrealized Losses | -2 | ' | -3 |
Fair Value | 4,495 | ' | 4,266 |
Financial Institution Instruments [Member] | ' | ' | ' |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Adjusted Cost | 4,874 | ' | 5,654 |
Gross Unrealized Gains | 6 | ' | 5 |
Gross Unrealized Losses | -1 | ' | -1 |
Fair Value | 4,879 | ' | 5,658 |
Government Debt [Member] | ' | ' | ' |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Adjusted Cost | 1,686 | ' | 1,932 |
Gross Unrealized Gains | 0 | ' | 1 |
Gross Unrealized Losses | 0 | ' | -1 |
Fair Value | 1,686 | ' | 1,932 |
Marketable Equity Securities [Member] | ' | ' | ' |
Available-For-Sale Investments [Abstract] | ' | ' | ' |
Gross Unrealized Gains | 2,764 | ' | 2,881 |
Gross Unrealized Losses | 0 | ' | 0 |
Adjusted Cost | 3,321 | ' | 3,340 |
Fair Value | $6,085 | ' | $6,221 |
Cash_and_Investments_Equity_Me
Cash and Investments, Equity Method Investments (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 | Dec. 28, 2013 |
Equity Method Investments Textual Details [Abstract] | ' | ' | ' |
Carrying Value | $1,107 | ' | $1,038 |
IM Flash Technologies, LLC [Member] | ' | ' | ' |
Equity Method Investments Textual Details [Abstract] | ' | ' | ' |
Ownership Percentage | 49.00% | ' | ' |
Carrying Value | 656 | ' | 646 |
Variable Interest Entity, Reporting Entity Involvement, Known Maximum Loss Exposure, Amount | 656 | ' | ' |
Percentage of purchase commitment of production output and production-related services | 49.00% | ' | ' |
Related Party Transactions [Abstract] | ' | ' | ' |
Related Party Transaction, Purchases from Related Party | 105 | 100 | ' |
Due to Related Parties | $100 | ' | $75 |
Cash_and_Investments_Trading_A
Cash and Investments, Trading Assets (Detail) (Marketable Debt Instruments [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Marketable Debt Instruments [Member] | ' | ' |
Schedule Of Trading Securities And Other Trading Assets [Line Items] | ' | ' |
Trading Securities, Change in Unrealized Holding Gain (Loss) | $79 | ($163) |
Net gains (losses) on derivatives related to trading securities | ($82) | $164 |
Inventories_Detail
Inventories (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Inventories [Abstract] | ' | ' |
Raw materials | $463 | $458 |
Work in process | 1,803 | 1,998 |
Finished goods | 1,497 | 1,716 |
Total Inventories | $3,763 | $4,172 |
Derivative_Financial_Instrumen2
Derivative Financial Instruments (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 | Dec. 28, 2013 |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | $22,484 | $22,187 | $23,739 |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 221 | ' | 325 |
Derivative Liability, Fair Value, Gross Liability | 391 | ' | 401 |
Offsetting Derivative Assets [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Liability | 0 | ' | 0 |
Derivative Asset, Fair Value, Amount Not Offset Against Collateral | 221 | ' | 325 |
Derivative, Collateral, Obligation to Return Securities | -158 | ' | -158 |
Derivative Asset, Collateral, Obligation To Return Cash Or Non-Cash | -9 | ' | -3 |
Derivative Asset, Fair Value, Amount Offset Against Collateral | 54 | ' | 164 |
Securities Purchased under Agreements to Resell, Gross | 582 | ' | 800 |
Securities Purchased under Agreements to Resell, Liability | 0 | ' | 0 |
Securities Purchased Under Agreements To Resell, Amount Not Offset Against Collateral | 582 | ' | 800 |
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities | 0 | ' | 0 |
Derivative Asset, Securities Purchased Under Agreements To Resell, Collateral, Obligation To Return Cash Or Non-Cash | -582 | ' | -800 |
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral | 0 | ' | 0 |
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Gross | 803 | ' | 1,125 |
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Liability | 0 | ' | 0 |
Derivative Asset, Securities Purchased Under Agreements To Resell, Securities Borrowed, Amount Not Offset Against Collateral | 803 | ' | 1,125 |
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities | -158 | ' | -158 |
Derivative Asset, Securities Purchased Under Agreements To Resell, Securities Borrowed, Collateral, Obligation To Return Cash Or Non-Cash | -591 | ' | -803 |
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Amount Offset Against Collateral | 54 | ' | 164 |
Offsetting Derivative Liabilities [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Asset | 0 | ' | 0 |
Derivative Liability, Fair Value, Amount Not Offset Against Collateral | 391 | ' | 401 |
Derivative, Collateral, Right to Reclaim Securities | -158 | ' | -158 |
Derivative Asset, Collateral, Collateral, Obligation To Reclaim Cash Or Non-Cash | -181 | ' | -32 |
Derivative Liability, Fair Value, Amount Offset Against Collateral | 52 | ' | 211 |
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Gross | 391 | ' | 401 |
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Asset | 0 | ' | 0 |
Derivative Liability, Securities Sold Under Agreements To Resell, Securities Loaned, Amount Not Offset Against Collateral | 391 | ' | 401 |
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities | -158 | ' | -158 |
Derivative Liability, Securities Sold Under Agreements To Resell, Securities Loaned, Collateral, Right To Reclaim Cash Or Non-Cash | -181 | ' | -32 |
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Amount Offset Against Collateral | 52 | ' | 211 |
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion) | 33 | -235 | ' |
Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in Income | -55 | 206 | ' |
Other Current Assets [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 242 | ' | 357 |
Other Current Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 86 | ' | 114 |
Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 156 | ' | 243 |
Other Long-Term Assets [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 35 | ' | 36 |
Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 1 |
Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 35 | ' | 35 |
Other Accrued Liabilities [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 362 | ' | 372 |
Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 56 | ' | 118 |
Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 306 | ' | 254 |
Other Long-Term Liabilities [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 47 | ' | 50 |
Other Long-Term Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 1 | ' | 2 |
Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 46 | ' | 48 |
Currency Forwards [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 11,729 | 13,141 | 13,404 |
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion) | 35 | -236 | ' |
Currency Forwards [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member] | ' | ' | ' |
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in Income | -15 | 56 | ' |
Currency Forwards [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 86 | ' | 114 |
Currency Forwards [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 36 | ' | 66 |
Currency Forwards [Member] | Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 1 |
Currency Forwards [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Currency Forwards [Member] | Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 53 | ' | 118 |
Currency Forwards [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 80 | ' | 63 |
Currency Forwards [Member] | Other Long-Term Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 1 | ' | 2 |
Currency Forwards [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Currency Interest Rate Swaps [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 4,795 | 3,464 | 4,377 |
Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member] | ' | ' | ' |
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in Income | -54 | 100 | ' |
Currency Interest Rate Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 104 | ' | 124 |
Currency Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 5 | ' | 6 |
Currency Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 197 | ' | 163 |
Currency Interest Rate Swaps [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 32 | ' | 29 |
Embedded Debt Derivatives [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 3,600 | 3,600 | 3,600 |
Embedded Debt Derivatives [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Embedded Debt Derivatives [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Embedded Debt Derivatives [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Embedded Debt Derivatives [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 14 | ' | 19 |
Interest Rate Swaps [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 1,311 | 1,041 | 1,377 |
Interest Rate Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 4 | ' | 5 |
Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 22 | ' | 28 |
Interest Rate Swaps [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Total Return Swaps [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 989 | 859 | 914 |
Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member] | Various [Member] | ' | ' | ' |
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in Income | 13 | 48 | ' |
Total Return Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 12 | ' | 48 |
Total Return Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Total Return Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 7 | ' | 0 |
Total Return Swaps [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Other Derivative Instruments [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 60 | 82 | 67 |
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in OCI on Derivatives (Effective Portion) | -2 | 1 | ' |
Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member] | Gains (losses) on equity investments, net [Member] | ' | ' | ' |
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ' | ' | ' |
Gains (Losses) Recognized in Income | 1 | 2 | ' |
Other Derivative Instruments [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Other Derivative Instruments [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Other Derivative Instruments [Member] | Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 0 | ' | 0 |
Other Derivative Instruments [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Asset, Fair Value, Gross Asset | 30 | ' | 29 |
Other Derivative Instruments [Member] | Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 3 | ' | 0 |
Other Derivative Instruments [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Other Derivative Instruments [Member] | Other Long-Term Liabilities [Member] | Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
Other Derivative Instruments [Member] | Other Long-Term Liabilities [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' |
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ' | ' | ' |
Derivative Liability, Fair Value, Gross Liability | 0 | ' | 0 |
British Pound Sterling [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 487 | 422 | 549 |
Chinese Yuan [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 1,291 | 572 | 1,116 |
Euro [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 6,199 | 6,800 | 6,874 |
Israeli Shekel [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 1,878 | 1,974 | 2,244 |
Japanese Yen [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 3,542 | 3,854 | 4,116 |
Malaysian Ringgit [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 524 | 520 | 506 |
Swiss Franc [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 1,256 | 1,312 | 1,189 |
Other Currencies [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | 1,347 | 1,151 | 1,187 |
Total Currency Exchange Rate Derivatives [Member] | ' | ' | ' |
Gross Notional Amounts [Abstract] | ' | ' | ' |
Derivative, Notional Amount | $16,524 | $16,605 | $17,781 |
Acquisitions_Detail
Acquisitions (Detail) (Series of Individually Immaterial Business Acquisitions [Member], USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 29, 2014 |
Series of Individually Immaterial Business Acquisitions [Member] | ' |
Acquisitions [Abstract] | ' |
Business Combinations During Period, Consideration Transferred | $108 |
Divestitures_Detail
Divestitures (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Divestitures Detail [Abstract] | ' | ' |
Proceeds from divestitures | $150 | $0 |
Goodwill_Detail
Goodwill (Detail) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 29, 2014 |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | $10,513 |
Goodwill, Transfers | 0 |
Goodwill, Effect of exchange rate fluctuations and other | 5 |
Goodwill, Ending Balance | 10,617 |
Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 99 |
PC Client Group [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 3,058 |
Goodwill, Transfers | 0 |
Goodwill, Effect of exchange rate fluctuations and other | 0 |
Goodwill, Ending Balance | 3,058 |
PC Client Group [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 0 |
Data Center Group [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 1,831 |
Goodwill, Transfers | 138 |
Goodwill, Effect of exchange rate fluctuations and other | 0 |
Goodwill, Ending Balance | 1,977 |
Data Center Group [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 8 |
Internet Of Things Group [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 0 |
Goodwill, Transfers | 428 |
Goodwill, Effect of exchange rate fluctuations and other | 0 |
Goodwill, Ending Balance | 428 |
Internet Of Things Group [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 0 |
Mobile And Communications Group [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 0 |
Goodwill, Transfers | 631 |
Goodwill, Effect of exchange rate fluctuations and other | 0 |
Goodwill, Ending Balance | 631 |
Mobile And Communications Group [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 0 |
Other Intel Architecture Operating Segments [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 1,075 |
Goodwill, Transfers | -1,075 |
Goodwill, Effect of exchange rate fluctuations and other | 0 |
Goodwill, Ending Balance | 0 |
Other Intel Architecture Operating Segments [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 0 |
Software and Services Operating Segments [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 4,549 |
Goodwill, Transfers | -140 |
Goodwill, Effect of exchange rate fluctuations and other | 23 |
Goodwill, Ending Balance | 4,432 |
Software and Services Operating Segments [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | 0 |
All Other [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Beginning Balance | 0 |
Goodwill, Transfers | 18 |
Goodwill, Effect of exchange rate fluctuations and other | -18 |
Goodwill, Ending Balance | 91 |
All Other [Member] | Series of Individually Immaterial Business Acquisitions [Member] | ' |
Goodwill [Roll Forward] | ' |
Goodwill, Additions due to acquisitions | $91 |
Identified_Intangible_Assets_F
Identified Intangible Assets, Finite-Lived Intangible Assets (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 | Dec. 28, 2013 |
Identified Intangible Assets By Major Class [Abstract] | ' | ' | ' |
Gross Assets, Finite-lived Intangible Assets | $7,851 | ' | $7,840 |
Accumulated Amortization | -3,806 | ' | -3,537 |
Net | 4,045 | ' | 4,303 |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of intangibles | 287 | 382 | ' |
Identified Intangible Assets, Future Amortization Expenses [Abstract] | ' | ' | ' |
Future Amortization Expense, Remainder of 2014 | 844 | ' | ' |
Future Amortization Expense, 2015 | 817 | ' | ' |
Future Amortization Expense, 2016 | 687 | ' | ' |
Future Amortization Expense, 2017 | 405 | ' | ' |
Future Amortization Expense, 2018 | 229 | ' | ' |
Acquisition-related Developed Technology [Member] | ' | ' | ' |
Identified Intangible Assets By Major Class [Abstract] | ' | ' | ' |
Gross Assets, Finite-lived Intangible Assets | 2,932 | ' | 2,922 |
Accumulated Amortization | -1,841 | ' | -1,691 |
Net | 1,091 | ' | 1,231 |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of acquisition-related intangibles | 146 | 140 | ' |
Identified Intangible Assets, Future Amortization Expenses [Abstract] | ' | ' | ' |
Future Amortization Expense, Remainder of 2014 | 434 | ' | ' |
Future Amortization Expense, 2015 | 303 | ' | ' |
Future Amortization Expense, 2016 | 211 | ' | ' |
Future Amortization Expense, 2017 | 63 | ' | ' |
Future Amortization Expense, 2018 | 41 | ' | ' |
Acquisition-related Customer Relationships [Member] | ' | ' | ' |
Identified Intangible Assets By Major Class [Abstract] | ' | ' | ' |
Gross Assets, Finite-lived Intangible Assets | 1,766 | ' | 1,760 |
Accumulated Amortization | -901 | ' | -828 |
Net | 865 | ' | 932 |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of acquisition-related intangibles | 70 | 70 | ' |
Identified Intangible Assets, Future Amortization Expenses [Abstract] | ' | ' | ' |
Future Amortization Expense, Remainder of 2014 | 200 | ' | ' |
Future Amortization Expense, 2015 | 252 | ' | ' |
Future Amortization Expense, 2016 | 234 | ' | ' |
Future Amortization Expense, 2017 | 142 | ' | ' |
Future Amortization Expense, 2018 | 29 | ' | ' |
Acquisition-related Trade Names [Member] | ' | ' | ' |
Identified Intangible Assets By Major Class [Abstract] | ' | ' | ' |
Gross Assets, Finite-lived Intangible Assets | 65 | ' | 65 |
Accumulated Amortization | -47 | ' | -44 |
Net | 18 | ' | 21 |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of acquisition-related intangibles | 3 | 3 | ' |
Identified Intangible Assets, Future Amortization Expenses [Abstract] | ' | ' | ' |
Future Amortization Expense, Remainder of 2014 | 7 | ' | ' |
Future Amortization Expense, 2015 | 8 | ' | ' |
Future Amortization Expense, 2016 | 3 | ' | ' |
Future Amortization Expense, 2017 | 0 | ' | ' |
Future Amortization Expense, 2018 | 0 | ' | ' |
Licensed Technology and Patents [Member] | ' | ' | ' |
Identified Intangible Assets By Major Class [Abstract] | ' | ' | ' |
Gross Assets, Finite-lived Intangible Assets | 3,088 | ' | 3,093 |
Accumulated Amortization | -1,017 | ' | -974 |
Net | 2,071 | ' | 2,119 |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of intangibles | 68 | 66 | ' |
Identified Intangible Assets, Future Amortization Expenses [Abstract] | ' | ' | ' |
Future Amortization Expense, Remainder of 2014 | 203 | ' | ' |
Future Amortization Expense, 2015 | 254 | ' | ' |
Future Amortization Expense, 2016 | 239 | ' | ' |
Future Amortization Expense, 2017 | 200 | ' | ' |
Future Amortization Expense, 2018 | 159 | ' | ' |
Other Intangible Assets [Member] | ' | ' | ' |
Identified Intangible Assets, Amortization Expenses [Abstract] | ' | ' | ' |
Amortization of intangibles | $0 | $103 | ' |
Identified_Intangible_Assets_I
Identified Intangible Assets, Indefinite-Lived Intangible Asset (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Indefinite-lived Intangible Assets [Line Items] | ' | ' |
Intangible Assets Gross | $918 | $847 |
Acquisition-related Trade Names [Member] | ' | ' |
Indefinite-lived Intangible Assets [Line Items] | ' | ' |
Gross Assets, Indefinite-Lived Intangible Assets | 821 | 818 |
Other Intangible Assets [Member] | ' | ' |
Indefinite-lived Intangible Assets [Line Items] | ' | ' |
Gross Assets, Indefinite-Lived Intangible Assets | $97 | $29 |
Identified_Intangible_Assets_T1
Identified Intangible Assets, Total Intangible Assets (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Identified Intangible Assets [Abstract] | ' | ' |
Identified intangible assets, gross | $8,769 | $8,687 |
Identified intangible assets, net | $4,963 | $5,150 |
Other_LongTerm_Assets_Detail
Other Long-Term Assets (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Dec. 28, 2013 |
Other Long-Term Assets Detail [Abstract] | ' | ' |
Equity method investments | $1,107 | $1,038 |
Non-marketable cost method investments | 1,285 | 1,270 |
Non-current deferred tax assets | 449 | 434 |
Loans receivable | 806 | 952 |
Prepayments For Property, Plant And Equipment | 457 | 521 |
Other | 1,342 | 1,274 |
Total other long-term assets | 5,446 | 5,489 |
Transfers From Other Long-Term Assets to Property, Plant, And Equipment | $117 | ' |
Restructuring_and_Asset_Impair2
Restructuring and Asset Impairment Charges (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Employee | ||
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and Related Cost, Incurred Cost | $137 | $0 |
Restructuring and Related Cost, Number of Impacted Employees | 2,200 | ' |
Restructuring and Related Cost, Cost Incurred to Date | 377 | ' |
Restructuring and Related Cost, Number of Impacted Employees, Inception to Date | 6,100 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Restructuring Reserve, Beginning Balance | 183 | ' |
Restructuring Reserve, Additional accruals | 139 | ' |
Restructuring Reserve, Adjustments | -2 | ' |
Restructuring Reserve, Cash payments | -57 | ' |
Restructuring Reserve, Ending Balance | 263 | ' |
Employee severance and benefit arrangements [Member] | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and Related Cost, Incurred Cost | 137 | 0 |
Restructuring and Related Cost, Cost Incurred to Date | 338 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Restructuring Reserve, Beginning Balance | 183 | ' |
Restructuring Reserve, Additional accruals | 139 | ' |
Restructuring Reserve, Adjustments | -2 | ' |
Restructuring Reserve, Cash payments | -57 | ' |
Restructuring Reserve, Ending Balance | 263 | ' |
Asset Impairments [Member] | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and Related Cost, Incurred Cost | 0 | 0 |
Restructuring and Related Cost, Cost Incurred to Date | 39 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Restructuring Reserve, Beginning Balance | 0 | ' |
Restructuring Reserve, Additional accruals | 0 | ' |
Restructuring Reserve, Adjustments | 0 | ' |
Restructuring Reserve, Cash payments | 0 | ' |
Restructuring Reserve, Ending Balance | $0 | ' |
Deferred_Income_Detail
Deferred Income (Detail) (USD $) | Mar. 29, 2014 | Dec. 28, 2013 |
In Millions, unless otherwise specified | ||
Deferred Income Detail [Abstract] | ' | ' |
Deferred income on shipments of components to distributors | $928 | $852 |
Deferred income from software and services operating segments | 1,243 | 1,244 |
Current deferred income | 2,171 | 2,096 |
Non-current deferred income from software and services operating segments | 482 | 506 |
Total deferred income | $2,653 | $2,602 |
Employee_Equity_Incentive_Plan2
Employee Equity Incentive Plans (Detail) (USD $) | 3 Months Ended | 3 Months Ended | 3 Months Ended | ||||||
In Millions, except Per Share data, unless otherwise specified | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 29, 2014 | Mar. 29, 2014 | Mar. 29, 2014 | Mar. 30, 2013 |
Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Market Based Restricted Stock Units [Member] | Stock Option Awards [Member] | Stock Option Awards [Member] | 2006 Equity Incentive Plan [Member] | Restricted Stock or Stock Units, 2006 Plan [Member] | Stock Purchase Plan [Member] | Stock Purchase Plan [Member] | |
Employee Equity Incentive Plans, (Textual) (Details) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | ' | ' | ' | ' | ' | 719 | 517 | 373 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | ' | ' | ' | ' | ' | 305 | ' | 206 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | ' | ' | ' | ' | ' | ' | ' | 85.00% | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | ' | ' | ' | ' | ' | ' | ' | 10.7 | 11.1 |
Share-based Compensation Arrangement by Share-based Payment Award, Employee Purchases, Amount | ' | ' | ' | ' | ' | ' | ' | $212 | $200 |
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units, Outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of RSUs outstanding, beginning balance | 113.3 | ' | 3.2 | ' | ' | ' | ' | ' | ' |
Number of RSUs granted | 3.6 | ' | ' | ' | ' | ' | ' | ' | ' |
Number of RSUs vested | -3.1 | ' | ' | ' | ' | ' | ' | ' | ' |
Number of RSUs forfeited | -2.7 | ' | ' | ' | ' | ' | ' | ' | ' |
Number of RSUs outstanding, ending balance | 111.1 | ' | 3.2 | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units, Weighted Average Exercise Price [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of RSU balance (in dollars per share) | $22.58 | $22.47 | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of granted RSUs (in dollars per share) | $26.28 | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of vested RSUs (in dollars per share) | $23.06 | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of forfeited RSUs (in dollars per share) | $22.44 | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of options outstanding, beginning balance | ' | ' | ' | 153 | ' | ' | ' | ' | ' |
Number of options granted | ' | ' | ' | 0.5 | ' | ' | ' | ' | ' |
Number of options exercised | ' | ' | ' | -13.9 | ' | ' | ' | ' | ' |
Number of options cancelled and forfeited | ' | ' | ' | -1.3 | ' | ' | ' | ' | ' |
Number of options expired | ' | ' | ' | -0.3 | ' | ' | ' | ' | ' |
Number of options outstanding, ending balance | ' | ' | ' | 138 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average exercise price of stock options (in dollars per share) | ' | ' | ' | $21.26 | $21.10 | ' | ' | ' | ' |
Weighted-average exercise price for stock option grants during the year (in dollars per share) | ' | ' | ' | $25.08 | ' | ' | ' | ' | ' |
Weighted-average exercise price for stock option exercises during the year (in dollars per share) | ' | ' | ' | $19.26 | ' | ' | ' | ' | ' |
Weighted-average exercise price for stock option cancellations and forfeitures during the year (in dollars per share) | ' | ' | ' | $23.48 | ' | ' | ' | ' | ' |
Weighted-average exercise price for stock option expirations during the year (in dollars per share) | ' | ' | ' | $31.34 | ' | ' | ' | ' | ' |
Number of options exercisable | ' | ' | ' | 102.3 | 111.5 | ' | ' | ' | ' |
Weighted-average exercise price for options exercisable (in dollars per share) | ' | ' | ' | $20.37 | $20.25 | ' | ' | ' | ' |
Common_Stock_Repurchases_Detai
Common Stock Repurchases (Detail) (Common Stock Repurchase Program [Member], USD $) | 3 Months Ended | |
Mar. 29, 2014 | Mar. 30, 2013 | |
Common Stock Repurchase Program [Member] | ' | ' |
Common Stock Repurchases (Textuals) [Abstract] | ' | ' |
Total Stock Repurchase Authorization End of Current Period, Value | $45,000,000,000 | ' |
Remaining Stock Repurchase Authorization End of Current Period, Value | 2,600,000,000 | ' |
Stock Repurchased and Retired During Period, Shares | 22,100,000 | 25,200,000 |
Stock Repurchased and Retired During Period, Value | 545,000,000 | 533,000,000 |
Accumulated Stock Repurchased During Program, Total Shares | 4,400,000,000 | ' |
Accumulated Stock Repurchased During Program, Total Value | $92,000,000,000 | ' |
Gains_Losses_on_Equity_Investm2
Gains (Losses) on Equity Investments, Net (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Gains (Losses) on Equity Investments, Net Detail [Abstract] | ' | ' |
Share of equity method investee losses, net | ($11) | ($23) |
Impairment charges | -38 | -17 |
Other, net | 26 | 10 |
Total gains (losses) on equity investments, net | 48 | -26 |
Equity Investments [Member] | ' | ' |
Gains (Losses) on Equity Investments, Net Detail [Abstract] | ' | ' |
Gains on sales, net | $71 | $4 |
Interest_and_Other_Net_Detail
Interest and Other, Net (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Interest and Other, Net Detail [Abstract] | ' | ' |
Interest income | $35 | $23 |
Interest expense | -37 | -73 |
Other, net | 114 | 0 |
Total interest and other, net | 112 | -50 |
Interest Costs, Capitalized During Period | $77 | $54 |
Earnings_Per_Share_Detail
Earnings Per Share (Detail) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Earnings Per Share [Abstract] | ' | ' |
Net income available to common stockholders | $1,930 | $2,045 |
Weighted average common shares outstanding—basic | 4,974 | 4,948 |
Dilutive effect of employee equity incentive plans (shares) | 76 | 78 |
Dilutive effect of convertible debt (shares) | 67 | 54 |
Weighted average common shares outstanding—diluted | 5,117 | 5,080 |
Basic earnings per common share (in dollars per share) | $0.39 | $0.41 |
Diluted earnings per common share (in dollars per share) | $0.38 | $0.40 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares) | 33 | 62 |
Other_Comprehensive_Income_Los2
Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 | Dec. 28, 2013 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax | $1,156 | ' | $1,243 |
Other comprehensive income before reclassifications | -57 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | -64 | ' | ' |
Tax effects | 34 | ' | ' |
Other comprehensive income (loss) | -87 | -11 | ' |
Unrealized holding gains (losses) on available-for-sale investments [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment Including Other Than Temporary Impairments, Net of Tax | 1,805 | ' | 1,882 |
Other comprehensive income before reclassifications | -55 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | -63 | ' | ' |
Tax effects | 41 | ' | ' |
Other comprehensive income (loss) | -77 | ' | ' |
Deferred Tax Asset Valuation Allowance [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Other comprehensive income before reclassifications | 0 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | 0 | ' | ' |
Tax effects | -2 | ' | ' |
Other comprehensive income (loss) | -2 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net Change In Deferred Tax Asset Valuation Allowance | 65 | ' | 67 |
Unrealized holding gains (losses) on derivatives [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Other comprehensive income before reclassifications | 33 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | -12 | ' | ' |
Tax effects | -7 | ' | ' |
Other comprehensive income (loss) | 14 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax | 18 | ' | 4 |
Prior service credits (costs) [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Other comprehensive income before reclassifications | -49 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | 1 | ' | ' |
Tax effects | 6 | ' | ' |
Other comprehensive income (loss) | -42 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net Prior Service Cost, Net Of Tax | -56 | ' | -14 |
Actuarial gains (losses) [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Other comprehensive income before reclassifications | -11 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | 10 | ' | ' |
Tax effects | -1 | ' | ' |
Other comprehensive income (loss) | -2 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net Actuarial Gains Loss, Net Of Tax | -604 | ' | -602 |
Foreign currency translation adjustment [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ' | ' | ' |
Other comprehensive income before reclassifications | 25 | ' | ' |
Amounts reclassified out of accumulated other comprehensive ncome | 0 | ' | ' |
Tax effects | -3 | ' | ' |
Other comprehensive income (loss) | 22 | ' | ' |
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | ($72) | ' | ($94) |
Other_Comprehensive_Income_Los3
Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Interest and other, net | $112 | ($50) |
Gains (losses) on equity investments, net | 48 | -26 |
Income before taxes | 2,670 | 2,443 |
Cost of sales | -5,151 | -5,514 |
Research and development | -2,846 | -2,527 |
Marketing, general and administrative | -2,047 | -1,947 |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | 9 | ' |
Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Income before taxes | 64 | -20 |
Unrealized holding gains (losses) on available-for-sale investments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Interest and other, net | 2 | 3 |
Gains (losses) on equity investments, net | 61 | 1 |
Income before taxes | 63 | 4 |
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Income before taxes | 12 | 2 |
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Currency Forwards [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Cost of sales | 2 | 0 |
Research and development | 8 | 3 |
Marketing, general and administrative | 2 | -1 |
Prior service credits (costs) [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax | -1 | -1 |
Actuarial gains (losses) [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax | -10 | -25 |
Amortization of pension and postretirement benefit components [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' |
Income before taxes | ($11) | ($26) |
Contingencies_Detail
Contingencies (Detail) | Aug. 19, 2010 | Jun. 30, 2012 | 31-May-09 | 31-May-09 | Dec. 31, 2008 | Oct. 31, 2010 |
Share data in Millions, except Per Share data, unless otherwise specified | McAfee, Inc. [Member] | McAfee, Inc. [Member] | EC Fine [Member] | EC Fine [Member] | Lehman Matter [Member] | Lehman Matter [Member] |
McAfee Shareholder Litigation [Member] | McAfee Shareholder Litigation [Member] | USD ($) | EUR (€) | USD ($) | Pending Litigation [Member] | |
USD ($) | Pending Litigation [Member] | USD ($) | ||||
USD ($) | ||||||
Loss Contingencies [Line Items] | ' | ' | ' | ' | ' | ' |
Loss Contingency, Fine | ' | ' | $1,447,000,000 | € 1,060,000,000 | ' | ' |
Loss Contingency, Pre-Payment Amount For Forward-Purchase Agreement | ' | ' | ' | ' | 1,000,000,000 | ' |
Loss Contingency, Cash Collateral Received For Forward-Purchase Agreement | ' | ' | ' | ' | 1,000,000,000 | ' |
Loss Contingency, Shares Of Intel Common Stock Required To Be Delivered Under Forward-Purchase Agreement | ' | ' | ' | ' | 50 | ' |
Loss Contingency, Cash Collateral Foreclosed On In Forward-Purchase Agreement | ' | ' | ' | ' | 1,000,000,000 | ' |
Loss Contingency, Damages Sought, Value | ' | ' | ' | ' | ' | $312,000,000 |
Loss Contingency, Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition | $48 | ' | ' | ' | ' | ' |
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages | ' | $62.08 | ' | ' | ' | ' |
Operating_Segments_Information2
Operating Segments Information (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 29, 2014 | Mar. 30, 2013 |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | $12,764 | $12,580 |
Operating income (loss) | 2,510 | 2,519 |
PC Client Group [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 7,941 | 8,054 |
Operating income (loss) | 2,802 | 2,488 |
Data Center Group [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 3,087 | 2,777 |
Operating income (loss) | 1,317 | 1,144 |
Internet Of Things Group [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 482 | 365 |
Operating income (loss) | 123 | 67 |
Mobile And Communications Group [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 156 | 404 |
Operating income (loss) | -929 | -703 |
Software and Services Operating Segments [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 553 | 520 |
Operating income (loss) | -7 | -6 |
All Other [Member] | ' | ' |
Schedule Of Segment Reporting Information [Abstract] | ' | ' |
Net revenue | 545 | 460 |
Operating income (loss) | ($796) | ($471) |